Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Dermatology

  Free Subscription


Articles published in Br J Dermatol

Retrieve available abstracts of 623 articles:
HTML format
Text format



Single Articles


    February 2019
  1. NAPOLITANO M, Megna M, Fabbrocini G, Nistico SP, et al
    Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition.
    Br J Dermatol. 2019 Feb 15. doi: 10.1111/bjd.17779.
    PubMed     Text format     Abstract available


  2. IRVINE AD, Mina-Osorio P
    Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide.
    Br J Dermatol. 2019 Feb 13. doi: 10.1111/bjd.17766.
    PubMed     Text format     Abstract available


  3. MASHAYEKHI S, Nast A, Gaskins M, Ahmed S, et al
    Hidden treasures: Exploring selective publication of trials and trial outcomes in biologic treatment for plaque psoriasis.
    Br J Dermatol. 2019 Feb 13. doi: 10.1111/bjd.17773.
    PubMed     Text format     Abstract available


  4. STOER NC, Botteri E, Ghiasvand R, Busund M, et al
    Reproductive factors and risk of melanoma: a population-based cohort study.
    Br J Dermatol. 2019 Feb 12. doi: 10.1111/bjd.17771.
    PubMed     Text format     Abstract available


  5. HALK AB, Potjer TP, Kukutsch NA, Vasen HFA, et al
    Surveillance for familial melanoma: recommendations from a national centre of expertise.
    Br J Dermatol. 2019 Feb 11. doi: 10.1111/bjd.17767.
    PubMed     Text format     Abstract available


  6. MERCIECA L, Lavery D, Warren RB, Griffiths CEM, et al
    Long-term, real world, efficacy of biologics for psoriasis: a single centre's experience.
    Br J Dermatol. 2019 Feb 9. doi: 10.1111/bjd.17756.
    PubMed     Text format     Abstract available


  7. TOTTE JEE, Pardo LM, Fieten KB, Vos MC, et al
    The nasal and skin microbiome are associated with disease severity in pediatric atopic dermatitis.
    Br J Dermatol. 2019 Feb 9. doi: 10.1111/bjd.17755.
    PubMed     Text format     Abstract available


  8. GUALDI G, Moro R, Regina V, Caravello S, et al
    PRISModegib: the use of the PRISM test to assess the Health-Related Quality of Life of patients with Locally Advanced Basal Cell Carcinoma undergoing Hedgehog Pathway Inhibitor Therapy.
    Br J Dermatol. 2019 Feb 9. doi: 10.1111/bjd.17754.
    PubMed     Text format     Abstract available


  9. RAN D, Cai M, Huang H, Zhou Y, et al
    Association analysis within MHC region of psoriasis vulgaris accounting for familial history.
    Br J Dermatol. 2019 Feb 8. doi: 10.1111/bjd.17747.
    PubMed     Text format     Abstract available


  10. VO S, Watanabe R, Koguchi-Yoshioka H, Matsumura Y, et al
    CD8 resident memory T cells with IL-17A-producing potential are accumulated in disease-naive non-lesional sites of psoriasis possibly in correlation with disease duration.
    Br J Dermatol. 2019 Feb 8. doi: 10.1111/bjd.17748.
    PubMed     Text format     Abstract available


  11. REICH K, Rich P, Maari C, Bissonnette R, et al
    Efficacy and Safety of Mirikizumab (LY3074828) in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results from a Randomised Phase 2 Study.
    Br J Dermatol. 2019 Feb 7. doi: 10.1111/bjd.17628.
    PubMed     Text format     Abstract available


  12. MAHIL SK, McSweeney SM, Kloczko E, McGowan B, et al
    Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A critically-appraised topic.
    Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17741.
    PubMed     Text format     Abstract available


  13. UD-DIN S, Foden P, Stocking K, Mazhari M, et al
    Objective assessment of dermal fibrosis in cutaneous scarring: using optical coherence tomography, high frequency ultrasound and immuno-histo-morphometry of human skin.
    Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17739.
    PubMed     Text format     Abstract available


  14. SANCLEMENTE G, Vasquez D, Aguirre D
    Construct validity and responsiveness of the Colombian version of Skindex-29.
    Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17742.
    PubMed     Text format     Abstract available


  15. SHARMA A, Adarsh MB, Dogra S, Vaiphei K, et al
    Evaluation of subclinical gut inflammation using fecal calprotectin levels and colonic mucosal biopsy in psoriasis and psoriatic arthritis patients.
    Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17745.
    PubMed     Text format     Abstract available


  16. MOURAD A, Straube S, Armijo-Olivo S, Gniadecki R, et al
    Factors Predicting Persistence of Biologic Drugs in Psoriasis: A Systematic Review and Meta-Analysis.
    Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17738.
    PubMed     Text format     Abstract available


  17. YOSIPOVITCH G, Reaney M, Mastey V, Eckert L, et al
    Peak Pruritus Numerical Rating Scale: Psychometric Validation and Responder Definition for Assessing Itch in Moderate-To-Severe Atopic Dermatitis.
    Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17744.
    PubMed     Text format     Abstract available


  18. PETERS N, Schubert M, Geppert JP, Moehrle M, et al
    Micrographic controlled surgery of basal cell carcinomas - Rapid Lump Examination (RLE) in comparison to H&E-stained paraffin sections.
    Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17740.
    PubMed     Text format     Abstract available


  19. STORAN ER, Woolf RT, Smith CH, Pink A, et al
    Clearance of molluscum contagiosum virus infection in patients with atopic eczema treated with dupilumab.
    Br J Dermatol. 2019 Feb 4. doi: 10.1111/bjd.17712.
    PubMed     Text format     Abstract available


  20. BLAUVELT A, Rosmarin D, Bieber T, Simpson EL, et al
    Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomic regions: data from phase 3 clinical trials.
    Br J Dermatol. 2019 Feb 4. doi: 10.1111/bjd.17703.
    PubMed     Text format     Abstract available


  21. ZOUTENDIJK J, Tio D, Koljenovic S, van den Bos RR, et al
    Nine percent of biopsy proven lentigo maligna are reclassified as lentigo maligna melanoma after surgery.
    Br J Dermatol. 2019 Feb 4. doi: 10.1111/bjd.17714.
    PubMed     Text format     Abstract available


  22. CHAN MP
    Refining the ever-evolving molecular landscape of spitzoid melanocytic neoplasms.
    Br J Dermatol. 2019;180:262.
    PubMed     Text format    


  23. GISONDI P
    Is the routine screening for hyperhomocysteinaemia recommended in patients with chronic plaque psoriasis?
    Br J Dermatol. 2019;180:262-263.
    PubMed     Text format    


  24. MISERY L
    Alexithymia and psoriasis: what is the link?
    Br J Dermatol. 2019;180:261.
    PubMed     Text format    


  25. GARCIA-DOVAL I, Albrecht J
    Who likes to perform the Psoriasis Area and Severity Index?
    Br J Dermatol. 2019;180:260-261.
    PubMed     Text format    


  26. ERFURT-BERGE C
    Influence on contact allergy of immune-mediated skin diseases such as psoriasis.
    Br J Dermatol. 2019;180:256-257.
    PubMed     Text format    


  27. MAGDALENO-TAPIAL J, Valenzuela-Onate C, Giacaman von der Weth MM, Ferrer-Guillen B, et al
    Image Gallery: Painful skin rash on the face after a 'chemsex' party.
    Br J Dermatol. 2019;180:e33.
    PubMed     Text format    


  28. XU Z, Lin Z
    Image Gallery: Cutaneous findings in an adult with X-linked reticulate pigmentary disorder.
    Br J Dermatol. 2019;180:e37.
    PubMed     Text format    


  29. ZHANG Y, Chen H
    Image Gallery: Generalized cutaneous Rosai-Dorfman disease presenting as acneiform lesions.
    Br J Dermatol. 2019;180:e36.
    PubMed     Text format    


    January 2019
  30. JEONG D, Aralis H, Bruhn KW, Cotliar J, et al
    A Reliability Study Using Network Oriented Research Assistant (NORA((R)) ) Examining the Use of Digital Photographs in the Assessment of Psoriasis.
    Br J Dermatol. 2019 Jan 31. doi: 10.1111/bjd.17702.
    PubMed     Text format     Abstract available


  31. SVENDSEN MT, Moller S, Feldman SR, Andersen KE, et al
    Socio-demographic factors do not have a large influence on psoriasis patients' adherence to topical treatment.
    Br J Dermatol. 2019 Jan 31. doi: 10.1111/bjd.17707.
    PubMed     Text format     Abstract available


  32. JOHNSON CM, Fitch K, Merola JF, Han J, et al
    Plasma TNF-alpha and adiponectin levels differentiate psoriatic arthritis from psoriasis patients.
    Br J Dermatol. 2019 Jan 29. doi: 10.1111/bjd.17700.
    PubMed     Text format     Abstract available


  33. SHAUB AR, Lewis ET, Nevedal AL, Swetter SM, et al
    Physician Perceptions of Primary Care-based Skin Cancer Screening in a Veterans Affairs Pilot Study.
    Br J Dermatol. 2019 Jan 29. doi: 10.1111/bjd.17699.
    PubMed     Text format     Abstract available


  34. SUN XL, Li LF
    Screening for hepatitis B virus and tuberculosis infection in patients with moderate-to-severe psoriasis recruiting for biologic therapy in China.
    Br J Dermatol. 2019 Jan 28. doi: 10.1111/bjd.17693.
    PubMed     Text format     Abstract available


  35. GILHOOLEY E, Daly S, Gallagher O, Glacken M, et al
    Experience of skin disease and relationships with healthcare providers: a qualitative study of Traveller women in Ireland.
    Br J Dermatol. 2019 Jan 28. doi: 10.1111/bjd.17697.
    PubMed     Text format     Abstract available


  36. PRAST-NIELSEN S, Tobin AM, Adamzik K, Powles A, et al
    Investigation of the Skin Microbiome: Swabs vs Biopsies.
    Br J Dermatol. 2019 Jan 28. doi: 10.1111/bjd.17691.
    PubMed     Text format     Abstract available


  37. HENRY AL, Bundy C, Kyle SD, Griffiths CEM, et al
    Understanding the experience of sleep disturbance in psoriasis: A qualitative exploration using the Common Sense, Self-Regulation Model.
    Br J Dermatol. 2019 Jan 23. doi: 10.1111/bjd.17685.
    PubMed     Text format     Abstract available


  38. DIKA E, Patrizi A, Lambertini M, Scarfi F, et al
    Comment on "Diagnostic accuracy of ex vivo fluorescence confocal microscopy for Mohs surgery of basal cell carcinomas: A prospective study on 753 margins".
    Br J Dermatol. 2019 Jan 23. doi: 10.1111/bjd.17686.
    PubMed     Text format     Abstract available


  39. MARTINEZ-DOMENECH A, Garcia-Legaz-Martinez M, Magdaleno-Tapial J, Torrecillas M, et al
    Anti-TNF-associated cutaneous leishmaniasis: a single-institution experience.
    Br J Dermatol. 2019 Jan 19. doi: 10.1111/bjd.17644.
    PubMed     Text format     Abstract available


  40. PASTERFIELD M, Clarke SA, R Thompson A
    A qualitative examination of the experience of skin camouflage by people living with visible skin conditions.
    Br J Dermatol. 2019 Jan 18. doi: 10.1111/bjd.17646.
    PubMed     Text format     Abstract available


  41. COUTURE-COSSETTE A, Morand M, Vinh DC, Gratton M, et al
    Severe disseminated Nocardia infection associated with ustekinumab treatment for psoriasis.
    Br J Dermatol. 2019 Jan 18. doi: 10.1111/bjd.17642.
    PubMed     Text format     Abstract available


  42. REHBINDER EM, Winger AJ, Landro L, Asarnoj A, et al
    Dry skin and skin barrier in early infancy.
    Br J Dermatol. 2019 Jan 13. doi: 10.1111/bjd.17626.
    PubMed     Text format     Abstract available


  43. OGUNSANYA ME, Cho SK, Hudson A, Chong BF, et al
    Validation and Reliability of a Disease-Specific Quality of Life Measure in Patients with Cutaneous Lupus Erythematosus: CLEQoL.
    Br J Dermatol. 2019 Jan 13. doi: 10.1111/bjd.17636.
    PubMed     Text format     Abstract available


  44. TAUBER M, Apoil PA, Richet C, Laurent J, et al
    Effect of dupilumab on atopic manifestations in patients treated for atopic dermatitis in real life practice.
    Br J Dermatol. 2019 Jan 11. doi: 10.1111/bjd.17629.
    PubMed     Text format     Abstract available


  45. THOREL D, Delcampe A, Ingen-Housz-Oro S, Hajj C, et al
    Dark skin phototype is associated with more severe ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Br J Dermatol. 2019 Jan 11. doi: 10.1111/bjd.17627.
    PubMed     Text format     Abstract available


  46. MCKENZIE S, Zang P, Blackcloud P, Cohen B, et al
    Case Series of Cutaneous Mucormycosis in Setting of Herpesviridae Infection.
    Br J Dermatol. 2019 Jan 11. doi: 10.1111/bjd.17631.
    PubMed     Text format     Abstract available


  47. AL-JANABI A, Jabbar-Lopez ZK, Griffiths CEM, Yiu ZZN, et al
    Risankizumab versus ustekinumab for plaque psoriasis: a critical appraisal.
    Br J Dermatol. 2019 Jan 11. doi: 10.1111/bjd.17624.
    PubMed     Text format     Abstract available


  48. HANSEN PR, Isaksen JL, Borut Jemec G, Ellervik C, et al
    Thyroid function in psoriasis.
    Br J Dermatol. 2019 Jan 10. doi: 10.1111/bjd.17622.
    PubMed     Text format     Abstract available


  49. MASON KJ, Williams S, Yiu ZZN, McElhone K, et al
    Persistence and Effectiveness of Non-Biologic Systemic Therapies for Moderate-Severe Psoriasis in Adults: a Systematic Review.
    Br J Dermatol. 2019 Jan 10. doi: 10.1111/bjd.17625.
    PubMed     Text format     Abstract available


  50. SOON SL, Ibrahim SF, Arron ST
    A randomised phase II study evaluating vismodegib as neoadjuvant treatment of basal cell carcinoma preceding Mohs micrographic surgery: results and lessons learned.
    Br J Dermatol. 2019 Jan 9. doi: 10.1111/bjd.17623.
    PubMed     Text format     Abstract available


  51. LEE YW, Won CH, Jung K, Nam HJ, et al
    Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial.
    Br J Dermatol. 2019 Jan 8. doi: 10.1111/bjd.17455.
    PubMed     Text format     Abstract available


  52. VAN DELFT LCJ, Essers BAB, Harnas S, Kelleners-Smeets NWJ, et al
    Quantitative survey into value clarification of discussed treatment options among patients treated for basal-cell carcinoma.
    Br J Dermatol. 2019 Jan 5. doi: 10.1111/bjd.17609.
    PubMed     Text format     Abstract available


  53. CARR DF, Wang CW, Bellon T, Ressel L, et al
    Serum and blister-fluid elevation and decreased epidermal content of HMGB1 protein in drug-induced Stevens Johnson syndrome/toxic epidermal necrolysis.
    Br J Dermatol. 2019 Jan 5. doi: 10.1111/bjd.17610.
    PubMed     Text format     Abstract available


  54. JIYAD Z, Akhras V
    Incidence of melanoma and outcomes of longitudinal melanonychia in a cohort of cases referred to a London dermatology department.
    Br J Dermatol. 2019 Jan 4. doi: 10.1111/bjd.17607.
    PubMed     Text format     Abstract available


  55. ENZAN N, Kitadate A, Tanaka A, Matsue K, et al
    Incisional random skin biopsy, not punch biopsy, is an appropriate method for diagnosis of intravascular large B-cell lymphoma: A clinicopathological study of 25 patients.
    Br J Dermatol. 2019 Jan 4. doi: 10.1111/bjd.17603.
    PubMed     Text format     Abstract available


  56. ROMITI R, Valenzuela F, Chouela EN, Xu W, et al
    Prevalence and outcome of latent tuberculosis in patients receiving ixekizumab: Integrated safety analysis from 11 clinical trials of patients with plaque psoriasis.
    Br J Dermatol. 2019 Jan 4. doi: 10.1111/bjd.17604.
    PubMed     Text format     Abstract available


  57. GARCIA-DOVAL I, Davila-Seijo P
    How real are 'real-life studies' in psoriasis, and the uncertain meaning of drug persistence.
    Br J Dermatol. 2019;180:15-16.
    PubMed     Text format    


  58. GISONDI P, Girolomoni G
    The multifaceted association between psoriasis and obesity.
    Br J Dermatol. 2019;180:24.
    PubMed     Text format    


  59. CHONG BF
    Applying the Cutaneous Lupus Erythematosus Disease Area and Severity Index to paediatric cutaneous lupus erythematosus.
    Br J Dermatol. 2019;180:20-21.
    PubMed     Text format    


  60. MAGIN P
    Patient preferences and patient-centredness in skin cancer care: implications for clinicians and patient management.
    Br J Dermatol. 2019;180:22-23.
    PubMed     Text format    


  61. SCHILLING B, Wiesner T
    Tackling melanoma by adjuvant therapy: why, whom and how?
    Br J Dermatol. 2019;180:1-2.
    PubMed     Text format    


  62. DANIELSEN K
    Increased risk of death in patients with psoriasis: disease or lifestyle?
    Br J Dermatol. 2019;180:3-4.
    PubMed     Text format    


  63. MOSS C
    RASopathies and the skin.
    Br J Dermatol. 2019;180:21.
    PubMed     Text format    


  64. ORMEROD AD
    Dutch guidelines for psoriasis treatment.
    Br J Dermatol. 2019;180:11.
    PubMed     Text format    


  65. CRIADO PR
    What lessons can we learn from an apparent decrease in the use of topical drugs for psoriasis?
    Br J Dermatol. 2019;180:19.
    PubMed     Text format    


  66. RYAN C
    Adalimumab treatment for psoriasis - safety in numbers.
    Br J Dermatol. 2019;180:14-15.
    PubMed     Text format    


  67. VAN DER KRAAIJ GE, Balak DMW, Busard CI, van Cranenburgh OD, et al
    Highlights of the updated Dutch evidence- and consensus-based guideline on psoriasis 2017.
    Br J Dermatol. 2019;180:31-42.
    PubMed     Text format    


  68. VAN AKKOOI ACJ, Hayes A
    Recent developments in lymph node surgery for melanoma.
    Br J Dermatol. 2019;180:5-7.
    PubMed     Text format    


  69. GRANTHAM HJ, Reynolds NJ
    The devil is in the data: differences in drug persistence between SNIIRAM, the French national health insurance database, and psoriasis biologics intervention registers.
    Br J Dermatol. 2019;180:8-10.
    PubMed     Text format    


  70. O'SHAUGHNESSY RFL
    Targeting tryptophan transport and breakdown in basal cell carcinoma.
    Br J Dermatol. 2019;180:16-17.
    PubMed     Text format    


  71. FLEMING P
    Tofacitinib: a new oral Janus kinase inhibitor for psoriasis.
    Br J Dermatol. 2019;180:13-14.
    PubMed     Text format    


    December 2018
  72. LARSEN MH, Strumse YAS, Borge CR, Osborne R, et al
    Health literacy - a new piece of the puzzle in psoriasis care?
    Br J Dermatol. 2018 Dec 31. doi: 10.1111/bjd.17595.
    PubMed     Text format     Abstract available


  73. VAN EGMOND S, Wakkee M, van Rengen A, Bastiaens MT, et al
    Factors influencing current low-value follow-up care after basal cell carcinoma and suggested strategies for de-adoption: a qualitative study.
    Br J Dermatol. 2018 Dec 30. doi: 10.1111/bjd.17594.
    PubMed     Text format     Abstract available


  74. BAKKER DS, Ariens LFM, van Luijk C, van der Schaft J, et al
    Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis.
    Br J Dermatol. 2018 Dec 30. doi: 10.1111/bjd.17538.
    PubMed     Text format     Abstract available


  75. SHEU JC, Tran J, Rady PL, Dao H Jr, et al
    Polyomaviruses of the Skin: Integrating Molecular and Clinical Advances in an Emerging Class of Viruses.
    Br J Dermatol. 2018 Dec 26. doi: 10.1111/bjd.17592.
    PubMed     Text format     Abstract available


  76. MIURA K, Olsen CM, Rea S, Marsden J, et al
    Do airline pilots and cabin crew have raised risks of melanoma and other skin cancers? Systematic review and meta-analysis.
    Br J Dermatol. 2018 Dec 26. doi: 10.1111/bjd.17586.
    PubMed     Text format     Abstract available


  77. KHOURY LR, Moller T, Zachariae C, Correll H, et al
    A prospective, clinical non-randomised controlled trial of individualised, nurse-led patient-centred intervention of patients with psoriasis.
    Br J Dermatol. 2018 Dec 26. doi: 10.1111/bjd.17585.
    PubMed     Text format     Abstract available


  78. FENTON GL, Smit AK, Keogh L, Cust AE, et al
    Exploring the Emotional and Behavioural Reactions to Receiving Personalised Melanoma Genomic Risk Information: A Qualitative Study.
    Br J Dermatol. 2018 Dec 22. doi: 10.1111/bjd.17582.
    PubMed     Text format     Abstract available


  79. RIJSBERGEN M, van der Kolk TN, Hogendoorn G, Kouwenhoven S, et al
    A randomised controlled proof-of-concept trial of digoxin and furosemide in adults with cutaneous warts.
    Br J Dermatol. 2018 Dec 22. doi: 10.1111/bjd.17583.
    PubMed     Text format     Abstract available


  80. LEE EH, Pusic AL, Cano SJ, Klassen AF, et al
    The FACE-Q Skin Cancer Module Addresses Post-Resection Aesthetic and Quality of Life Outcomes.
    Br J Dermatol. 2018 Dec 18. doi: 10.1111/bjd.17525.
    PubMed     Text format     Abstract available


  81. ERSSER SJ, Effah A, Dyson J, Kellar I, et al
    Effectiveness of interventions to support the early detection of skin-cancer through skin self-examination: a systematic review and meta-analysis.
    Br J Dermatol. 2018 Dec 18. doi: 10.1111/bjd.17529.
    PubMed     Text format     Abstract available


  82. DOBBS TD, Samarendra H, Hughes S, Hutchings HA, et al
    The FACE-Q Skin Cancer Module Addresses Post-Resection Aesthetic and Quality of Life Outcomes: Reply from Authors.
    Br J Dermatol. 2018 Dec 18. doi: 10.1111/bjd.17526.
    PubMed     Text format     Abstract available


  83. FICHMAN V, do Valle ACF, Freitas DFS, Sampaio FMS, et al
    Cryosurgery for the treatment of cutaneous sporotrichosis: Experience with 199 cases.
    Br J Dermatol. 2018 Dec 18. doi: 10.1111/bjd.17532.
    PubMed     Text format     Abstract available


  84. GILSON D, Whittaker SJ, Child FJ, Scarisbrick JJ, et al
    British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018.
    Br J Dermatol. 2018 Dec 17. doi: 10.1111/bjd.17240.
    PubMed     Text format    


  85. PALMGREN J, Paoli J, Schmidtchen A, Saleh K, et al
    Variability in the Diagnosis of Surgical Site Infections After Full-Thickness Skin Grafting: An International Survey.
    Br J Dermatol. 2018 Dec 10. doi: 10.1111/bjd.17517.
    PubMed     Text format     Abstract available


  86. NAJERA L, Alonso-Juarranz M, Garrido M, Ballestin C, et al
    Prognostic implications of markers of the metabolic phenotype in human cutaneous melanoma.
    Br J Dermatol. 2018 Dec 7. doi: 10.1111/bjd.17513.
    PubMed     Text format     Abstract available


  87. REINDERS MGHC, Cosgun B, Gijezen LMC, van Oosterhoud CN, et al
    Genetic profiling of basal cell carcinomas detects postzygotic mosaicism in basal cell naevus syndrome.
    Br J Dermatol. 2018 Dec 5. doi: 10.1111/bjd.17337.
    PubMed     Text format     Abstract available


  88. FOX JA, Langbecker D, Rosenberg J, Ekberg S, et al
    Uncertain diagnosis and prognosis in advanced melanoma: A qualitative study of the experiences of bereaved carers in a time of immune and targeted therapies.
    Br J Dermatol. 2018 Dec 4. doi: 10.1111/bjd.17511.
    PubMed     Text format     Abstract available


  89. LONGO C, Pampena R, Bombonato C, Gardini S, et al
    Diagnostic accuracy of ex vivo fluorescence confocal microscopy for Mohs surgery of basal cell carcinomas: a prospective study on 753 margins.
    Br J Dermatol. 2018 Dec 4. doi: 10.1111/bjd.17507.
    PubMed     Text format     Abstract available


  90. MOSCARELLA E, Ronchi A, Agozzino M, Franco R, et al
    Image Gallery: Dermoscopy of lichen amyloidosis.
    Br J Dermatol. 2018;179:e231.
    PubMed     Text format    


  91. CHALMERS RJG
    Documenting and defining psoriasis severity: an ongoing challenge.
    Br J Dermatol. 2018;179:1244-1245.
    PubMed     Text format    


  92. COUGHLIN CC, Siegel DH
    Cutaneous findings in paediatric solid organ transplant recipients.
    Br J Dermatol. 2018;179:1235-1236.
    PubMed     Text format    


  93. ELOSUA-GONZALEZ M, Lopez-Estebaranz JL, Pampin-Franco A, Garcia-Zamora E, et al
    Image Gallery: Cutaneous lesions of Erdheim-Chester disease treated with carbon dioxide laser therapy.
    Br J Dermatol. 2018;179:e228.
    PubMed     Text format    


  94. LIM HW
    Shedding light on photodynamic therapy for basal cell carcinoma.
    Br J Dermatol. 2018;179:1240-1241.
    PubMed     Text format    


  95. HATA H
    Can we manage refractory cutaneous angiosarcoma?
    Br J Dermatol. 2018;179:1246.
    PubMed     Text format    


  96. DABAS G, Dogra S, Kaushik A, Narang T, et al
    Image Gallery: Multiple cutaneous and oral nodules in histoid leprosy.
    Br J Dermatol. 2018;179:e227.
    PubMed     Text format    


    November 2018
  97. MISERY L, Ezzedine K, Corgibet F, Dupin N, et al
    Sex- and age-adjusted prevalence estimates of skin types and unpleasant skin sensations and their consequences on the quality of life: Results from a study of a large representative sample of the French population.
    Br J Dermatol. 2018 Nov 30. doi: 10.1111/bjd.17467.
    PubMed     Text format     Abstract available


  98. CORRIE PG, Terheyden P, Ten Tije AJ, Herbst R, et al
    A prospective, observational safety study of patients with BRAF(V) (600) -mutated unresectable or metastatic melanoma treated with vemurafenib [Zelboraf Safety Study (ZeSS)].
    Br J Dermatol. 2018 Nov 29. doi: 10.1111/bjd.17465.
    PubMed     Text format     Abstract available


  99. REICH K, Papp KA, Armstrong AW, Wasfi Y, et al
    Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomised VOYAGE 1 and VOYAGE 2 studies.
    Br J Dermatol. 2018 Nov 28. doi: 10.1111/bjd.17454.
    PubMed     Text format     Abstract available


  100. MENZIES S, Daly S, McKenna DB
    Social media and psoriasis treatment: What are people saying on Twitter?
    Br J Dermatol. 2018 Nov 25. doi: 10.1111/bjd.17452.
    PubMed     Text format     Abstract available


  101. SIMPSON RC, Cooper SM, Kirtschig G, Larsen S, et al
    Future research priorities for lichen sclerosus - results of a James Lind Alliance Priority Setting Partnership.
    Br J Dermatol. 2018 Nov 25. doi: 10.1111/bjd.17447.
    PubMed     Text format     Abstract available


  102. LAGRELIUS M, Wahlgren CF, Matura M, Bergstrom A, et al
    Atopic dermatitis at preschool age and contact allergy in adolescence: a population-based cohort study.
    Br J Dermatol. 2018 Nov 22. doi: 10.1111/bjd.17449.
    PubMed     Text format     Abstract available


  103. SIEGEL S, Winthrop K, Ehst B, Ortega Loayza A, et al
    Ustekinumab use in patients with severe psoriasis co-infected with hepatitis B and/or C.
    Br J Dermatol. 2018 Nov 20. doi: 10.1111/bjd.17444.
    PubMed     Text format     Abstract available


  104. POTRONY M, Puig-Butille JA, Ribera-Sola M, Iyer V, et al
    POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
    Br J Dermatol. 2018 Nov 19. doi: 10.1111/bjd.17443.
    PubMed     Text format     Abstract available


  105. MAEDA T, Yoshino K, Nagai K, Oaku S, et al
    Efficacy of nivolumab monotherapy against acral lentiginous melanoma and mucosal melanoma in Asian patients.
    Br J Dermatol. 2018 Nov 17. doi: 10.1111/bjd.17434.
    PubMed     Text format     Abstract available


  106. OKIYAMA N, Inoue S, Saito A, Nakamura Y, et al
    Antihelix/helix violaceous macules in Japanese patients with anti-melanoma differentiation-associated protein 5 (MDA5) antibody-associated dermatomyositis.
    Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17431.
    PubMed     Text format     Abstract available


  107. HAMPRAS SS, Tommasino M, Zhao Y, Messina J, et al
    Cross-sectional associations between cutaneous viral infections and regulatory T lymphocytes in circulation.
    Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17429.
    PubMed     Text format     Abstract available


  108. SCRIVENS LJ, Goulding JMR, Allen KJ
    The views of consultant dermatologists on creating centralised skin lesion units.
    Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17427.
    PubMed     Text format     Abstract available


  109. HAYASHI M, Igarashi A, Okamura K, Suzuki T, et al
    Paradoxical exacerbation of latent interstitial pneumonia by secukinumab in a patient with psoriasis vulgaris.
    Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17424.
    PubMed     Text format     Abstract available


  110. YIU ZZN, Sorbe C, Lunt M, Rustenbach SJ, et al
    Development and Validation of a Multivariable Risk Prediction Model for Serious Infection in Patients with Psoriasis Receiving Systemic Therapy.
    Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17421.
    PubMed     Text format     Abstract available


  111. VERAITCH O, Lewis F, Craythorne E, Calonje E, et al
    Management of vulval melanoma in situ with imiquimod.
    Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17433.
    PubMed     Text format     Abstract available


  112. GENDREAU S, Amiot A, Le Baleur Y, Charpy C, et al
    Gastro-intestinal involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis : a retrospective case series.
    Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17428.
    PubMed     Text format     Abstract available


  113. AUGUSTIN M, Sommer R, Kirsten N, Danckworth A, et al
    Topology of Psoriasis in Routine Care - Results from a High-resolution Analysis in 2,009 Patients.
    Br J Dermatol. 2018 Nov 14. doi: 10.1111/bjd.17403.
    PubMed     Text format     Abstract available


  114. FREW JW
    We Need to Talk About Notch:Notch Dysregulation as an Epiphenomenon in Inflammatory Skin Disease.
    Br J Dermatol. 2018 Nov 11. doi: 10.1111/bjd.17414.
    PubMed     Text format     Abstract available


  115. MEGNA M, Pecoraro A, Balato N, Villani A, et al
    Psoriasis in a cohort of patients with common variable immunodeficiency.
    Br J Dermatol. 2018 Nov 10. doi: 10.1111/bjd.17408.
    PubMed     Text format     Abstract available


  116. NOVOA M, Baselga E, Beltran S, Giraldo L, et al
    Interventions for infantile haemangiomas of the skin: abridged Cochrane systematic review including GRADE assessments.
    Br J Dermatol. 2018 Nov 10. doi: 10.1111/bjd.17407.
    PubMed     Text format     Abstract available


  117. KOSUMI H, Natsuga K, Watanabe M, Okada K, et al
    Multiple cutaneous reticulohistiocytomas after haematopoietic cell transplantation: contribution of donor and host-derived cells.
    Br J Dermatol. 2018 Nov 8. doi: 10.1111/bjd.17406.
    PubMed     Text format     Abstract available


  118. ROUSSET L, Halioua B
    Psychological impact of psoriasis on Vlamidir Nabokov.
    Br J Dermatol. 2018 Nov 5. doi: 10.1111/bjd.17331.
    PubMed     Text format     Abstract available


  119. LI L, You J, Fu X, Wang Z, et al
    Variants of CARD14 are predisposing factors for generalized pustular psoriasis (GPP) with psoriasis vulgaris but not for GPP alone in a Chinese population.
    Br J Dermatol. 2018 Nov 2. doi: 10.1111/bjd.17392.
    PubMed     Text format     Abstract available


  120. TANEW A, Lim HW
    Phototherapy for psoriasis - outdated or underused?
    Br J Dermatol. 2018;179:1019-1020.
    PubMed     Text format    


  121. FERRARA G, Delfino M, Nappa P, Gelsomina M, et al
    Image Gallery: Cutaneous Langerhans cell histiocytosis: a clinical masquerade.
    Br J Dermatol. 2018;179:e197.
    PubMed     Text format    


  122. SCHMIDT SAJ
    Widely used antihypertensive drugs linked to cutaneous squamous cell carcinoma.
    Br J Dermatol. 2018;179:1027-1028.
    PubMed     Text format    


  123. IANHEZ M
    Skin field cancerization - an in vivo model to prevent nonmelanoma skin cancer: expanding the alternatives for treatment.
    Br J Dermatol. 2018;179:1026-1027.
    PubMed     Text format    


  124. MARUTHAPPU T, Posafalvi A, Castelletti S, Delaney PJ, et al
    Loss of function desmoplakin I and II mutations underlie dominant arrhythmogenic cardiomyopathy with a hair and skin phenotype.
    Br J Dermatol. 2018 Nov 1. doi: 10.1111/bjd.17388.
    PubMed     Text format     Abstract available


    October 2018
  125. FRIIS NU, Hoffmann N, Gyldenlove M, Skov L, et al
    Glucose metabolism in patients with psoriasis.
    Br J Dermatol. 2018 Oct 30. doi: 10.1111/bjd.17349.
    PubMed     Text format     Abstract available


  126. CRANWELL WC, Sinclair R
    Sunscreen and facial skin care products in frontal fibrosing alopecia: a case control study.
    Br J Dermatol. 2018 Oct 27. doi: 10.1111/bjd.17354.
    PubMed     Text format     Abstract available


  127. DOBBS TD, Samarendra H, Hughes S, Hutchings HA, et al
    Patient reported outcome measures for facial skin cancer: A systematic review and evaluation of the quality of their measurement properties.
    Br J Dermatol. 2018 Oct 26. doi: 10.1111/bjd.17342.
    PubMed     Text format     Abstract available


  128. DANILENKO M, Hodgson K, Stones R, Husain A, et al
    Diverse assays from a single skin punch biopsy to assess topical drug intervention.
    Br J Dermatol. 2018 Oct 26. doi: 10.1111/bjd.17353.
    PubMed     Text format     Abstract available


  129. REICH K, Sullivan J, Arenberger P, Mrowietz U, et al
    Effect of secukinumab on clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial.
    Br J Dermatol. 2018 Oct 26. doi: 10.1111/bjd.17351.
    PubMed     Text format     Abstract available


  130. ELLIS AG, Flohr C, Drucker AM
    Network meta-analyses of systemic treatments for psoriasis: a critical appraisal.
    Br J Dermatol. 2018 Oct 22. doi: 10.1111/bjd.17335.
    PubMed     Text format     Abstract available


  131. BONNET P, Battistella M, Bouaziz JD, Ram-Wolff C, et al
    Thymic localization of erythrodermic cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Oct 19. doi: 10.1111/bjd.17340.
    PubMed     Text format     Abstract available


  132. VERYKIOU S, Alexander M, Edwards N, Plummer R, et al
    Harnessing autophagy to overcome MEK-inhibitor induced resistance in metastatic melanoma.
    Br J Dermatol. 2018 Oct 19. doi: 10.1111/bjd.17333.
    PubMed     Text format     Abstract available


  133. SMIRNOVA J, von Kobyletzki L, Lindberg M, Svensson A, et al
    Atopic dermatitis, educational attainment and psychological functioning: a national cohort study.
    Br J Dermatol. 2018 Oct 19. doi: 10.1111/bjd.17330.
    PubMed     Text format     Abstract available


  134. LANGLEY RG, Armstrong AW, Lebwohl MG, Blauvelt A, et al
    Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase 3 trials.
    Br J Dermatol. 2018 Oct 17. doi: 10.1111/bjd.17318.
    PubMed     Text format     Abstract available


  135. AUGUSTIN M, Langenbruch A, Gutknecht M, Reich K, et al
    Definition of psoriasis severity in routine clinical care: current guidelines fail to capture the complexity of long-term psoriasis management.
    Br J Dermatol. 2018 Oct 17. doi: 10.1111/bjd.17128.
    PubMed     Text format     Abstract available


  136. DE GIORGI V, Salvati L, Barchielli A, Caldarella A, et al
    The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a population-based study.
    Br J Dermatol. 2018 Oct 16. doi: 10.1111/bjd.17321.
    PubMed     Text format     Abstract available


  137. EMTENANI S, Yuan H, Lin C, Pan M, et al
    Normal human skin is superior to monkey esophagus substrate for detection of circulating BP180-NC16A-specific immunoglobulin G antibodies in bullous pemphigoid.
    Br J Dermatol. 2018 Oct 13. doi: 10.1111/bjd.17313.
    PubMed     Text format     Abstract available


  138. DESCHAMPS O, Ram-Wolff C, Beylot-Barry M, Grange F, et al
    Treatment of mycosis fungoides and Sezary syndrome with romidepsin: a series of 32 cases of the French Study Group for Cutaneous Lymphoma.
    Br J Dermatol. 2018 Oct 9. doi: 10.1111/bjd.17269.
    PubMed     Text format     Abstract available


  139. ZILL JM, Christalle E, Tillenburg N, Mrowietz U, et al
    Effects of psychosocial interventions on patient-reported outcomes in patients with psoriasis: A systematic review and meta-analysis.
    Br J Dermatol. 2018 Oct 6. doi: 10.1111/bjd.17272.
    PubMed     Text format     Abstract available


  140. PILKINGTON SM, Barron MJ, Watson REB, Griffiths CEM, et al
    Aged human skin accumulates mast cells with altered functionality which localise to macrophage and VIP(+) nerve fibres.
    Br J Dermatol. 2018 Oct 6. doi: 10.1111/bjd.17268.
    PubMed     Text format     Abstract available


  141. HEFEZ L, Zaghbib K, Sbidian E, Valeyrie-Allanore L, et al
    Post-traumatic stress disorder in Stevens-Johnson syndrome and toxic epidermal necrolysis: prevalence and risk factors. A prospective study of 31 patients.
    Br J Dermatol. 2018 Oct 3. doi: 10.1111/bjd.17267.
    PubMed     Text format     Abstract available


  142. PLUMPTRE I, Stuart G, Cerullo A, Kinsler V, et al
    Use of sedation instead of general anaesthesia for screening MRI in congenital melanocytic naevi under the age of 1 year is a successful, safe, and economical first line approach.
    Br J Dermatol. 2018 Oct 3. doi: 10.1111/bjd.17263.
    PubMed     Text format     Abstract available


  143. BECHER G, Burden AD
    Ixekizumab in genital psoriasis.
    Br J Dermatol. 2018;179:811-812.
    PubMed     Text format    


  144. LLOYD-LAVERY A
    Long-term safety data for tofacitinib, an oral Janus kinase inhibitor, for the treatment for psoriasis.
    Br J Dermatol. 2018;179:815-816.
    PubMed     Text format    


  145. LEUNG DYM
    Can antibiotics be harmful in atopic dermatitis?
    Br J Dermatol. 2018;179:807-808.
    PubMed     Text format    


  146. CHEN Z
    What's new about the mechanism of methotrexate action in psoriasis?
    Br J Dermatol. 2018;179:818-819.
    PubMed     Text format    


  147. FUJIMOTO M, Inaba Y, Takahashi T, Nakanishi G, et al
    Image Gallery: Granulomatous dermatitis due to infection with the chlorophyllic green alga Desmodesmus.
    Br J Dermatol. 2018;179:e167.
    PubMed     Text format    


  148. MIURA H
    Image Gallery: 308-nm ultraviolet B excimer laser treatment for cutaneous B-cell lymphoma nodular lesions on the face.
    Br J Dermatol. 2018;179:e166.
    PubMed     Text format    


  149. TRAUPE H
    Revealing the mysteries of X-linked recessive ichthyosis.
    Br J Dermatol. 2018;179:821-822.
    PubMed     Text format    


  150. DRUCKER AM, Bercovitch L
    Generating new evidence for old medications: the TREAT trial in paediatric atopic dermatitis.
    Br J Dermatol. 2018;179:813-814.
    PubMed     Text format    


    September 2018
  151. SAMPOGNA F, Puig L, Spuls P, Girolomoni G, et al
    Reversibility of alexithymia with effective treatment of moderate to severe psoriasis: longitudinal data from EPIDEPSO.
    Br J Dermatol. 2018 Sep 30. doi: 10.1111/bjd.17259.
    PubMed     Text format     Abstract available


  152. TARAZI M, Gaffney RG, Pearson D, Kushner CJ, et al
    Fatigue in systemic lupus erythematosus and other autoimmune skin diseases.
    Br J Dermatol. 2018 Sep 30. doi: 10.1111/bjd.17257.
    PubMed     Text format     Abstract available


  153. YAN JJ, Qiao M, Li RH, Zhao XT, et al
    Downregulation of miR-145-5p contributes to hyperproliferation of keratinocytes and skin inflammation in psoriasis.
    Br J Dermatol. 2018 Sep 30. doi: 10.1111/bjd.17256.
    PubMed     Text format     Abstract available


  154. DEENEN NJ, Koens L, Jaspars EH, Vermeer MH, et al
    Pitfalls in diagnosing primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
    Br J Dermatol. 2018 Sep 27. doi: 10.1111/bjd.17252.
    PubMed     Text format     Abstract available


  155. KOREKAWA A, Akasaka E, Rokunohe D, Fukui T, et al
    Nagashima-type palmoplantar keratoderma and malignant melanoma in Japanese patients.
    Br J Dermatol. 2018 Sep 26. doi: 10.1111/bjd.17251.
    PubMed     Text format     Abstract available


  156. ROGIERS A, Thomas D, Vander Borght S, van den Oord JJ, et al
    Dabrafenib plus trametinib in BRAF K601E-mutant melanoma.
    Br J Dermatol. 2018 Sep 24. doi: 10.1111/bjd.17250.
    PubMed     Text format     Abstract available


  157. PATEL K, Singam V, Vakharia PP, Chopra R, et al
    Measurement properties of three assessments of burden used in atopic dermatitis in adults.
    Br J Dermatol. 2018 Sep 23. doi: 10.1111/bjd.17243.
    PubMed     Text format     Abstract available


  158. MARANO AL, Clarke JM, Morse MA, Shah A, et al
    Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death (PD)-1 therapy.
    Br J Dermatol. 2018 Sep 23. doi: 10.1111/bjd.17245.
    PubMed     Text format     Abstract available


  159. LIOPYRIS K, Navarrete-Dechent C, Yelamos O, Marchetti MA, et al
    Clinical, dermoscopic and reflectance confocal microscopy characterization of facial basal cell carcinomas presenting as small white lesions on sun-damaged skin.
    Br J Dermatol. 2018 Sep 21. doi: 10.1111/bjd.17241.
    PubMed     Text format     Abstract available


  160. EGEBERG A, Thyssen JP, Wu JJ, Skov L, et al
    Risk of first-time and recurrent depression in patients with psoriasis - a population-based cohort study.
    Br J Dermatol. 2018 Sep 19. doi: 10.1111/bjd.17208.
    PubMed     Text format     Abstract available


  161. REDDY N, Nguyen BT
    The utility of optical coherence tomography for diagnosis of basal cell carcinoma: A quantitative review.
    Br J Dermatol. 2018 Sep 14. doi: 10.1111/bjd.17201.
    PubMed     Text format     Abstract available


  162. XU S, Stump TK, Jain J, Alshurafa N, et al
    Variation in daily ultraviolet light exposure and sun protection behaviours of melanoma survivors: an observational single-arm pilot study with a wearable sensor.
    Br J Dermatol. 2018 Sep 12. doi: 10.1111/bjd.17196.
    PubMed     Text format     Abstract available


  163. PAPP KA, Gooderham M, Jenkins R, Vender R, et al
    GM-CSF as a therapeutic target in psoriasis: randomised, controlled investigation using namilumab - a specific, human anti-GM-CSF monoclonal antibody.
    Br J Dermatol. 2018 Sep 12. doi: 10.1111/bjd.17195.
    PubMed     Text format     Abstract available


  164. VAN LEE CB, Roorda BM, Wakkee M, Voorham Q, et al
    Recurrence rate of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery versus standard excision: a retrospective cohort study.
    Br J Dermatol. 2018 Sep 10. doi: 10.1111/bjd.17188.
    PubMed     Text format     Abstract available


  165. SCHREINER M, Baumler W, Eckl D, Spath A, et al
    Photodynamic inactivation of bacteria to decolonize Methicillin resistant Staphylococcus aureus (MRSA) from human skin.
    Br J Dermatol. 2018 Sep 7. doi: 10.1111/bjd.17152.
    PubMed     Text format     Abstract available


  166. LARSABAL M, Ly S, Sbidian E, Moyal-Barracco M, et al
    "GENIPSO": a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis.
    Br J Dermatol. 2018 Sep 6. doi: 10.1111/bjd.17147.
    PubMed     Text format     Abstract available


  167. STROBER BE, Gottlieb AB, van de Kerkhof PCM, Puig L, et al
    Benefit-risk of tofacitinib in patients with moderate to severe chronic plaque psoriasis: Pooled analysis across 6 clinical trials.
    Br J Dermatol. 2018 Sep 6. doi: 10.1111/bjd.17149.
    PubMed     Text format     Abstract available


  168. SCHAUER F, Kern JS, Virtic O, Technau-Hafsi K, et al
    A new clinical variant of acquired reactive perforating dermatosis-like bullous pemphigoid.
    Br J Dermatol. 2018 Sep 6. doi: 10.1111/bjd.17146.
    PubMed     Text format     Abstract available


  169. GISONDI P, Bianchi L, Calzavara-Pinton P, Conti A, et al
    Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis. Data from the Psobiosimilars registry.
    Br J Dermatol. 2018 Sep 5. doi: 10.1111/bjd.17133.
    PubMed     Text format     Abstract available


  170. WANG X, Wang A, Wang X, Li R, et al
    Cutaneous Mucormycosis caused by Mucor irregularis in a patient with CARD9 deficiency.
    Br J Dermatol. 2018 Sep 5. doi: 10.1111/bjd.17144.
    PubMed     Text format     Abstract available


  171. BRANCACCIO G, Napolitano S, Troiani T, Franco R, et al
    Eighth American Joint Committee on Cancer (AJCC) melanoma classification: what about stage IIC?
    Br J Dermatol. 2018 Sep 5. doi: 10.1111/bjd.17145.
    PubMed     Text format     Abstract available


  172. THIESEN I, Wehkamp U, Bruggemann M, Ritgen M, et al
    Skin involvement by chronic lymphocytic leukemia is frequently associated with unrelated neoplastic or inflammatory cutaneous disease and is not indicative of general disease progression.
    Br J Dermatol. 2018 Sep 5. doi: 10.1111/bjd.17135.
    PubMed     Text format     Abstract available


  173. MATTHEWS NH, Risica PM, Ferris LK, Beatson M, et al
    Psychosocial impact of skin biopsies in the setting of melanoma screening - A cross-sectional survey.
    Br J Dermatol. 2018 Sep 5. doi: 10.1111/bjd.17134.
    PubMed     Text format     Abstract available


  174. ALBRECHT S, Jung S, Muller R, Lademann J, et al
    Skin type differences in solar simulated radiation-induced oxidative stress.
    Br J Dermatol. 2018 Sep 3. doi: 10.1111/bjd.17129.
    PubMed     Text format     Abstract available


  175. GKOGKOLOU P, Sarna M, Sarna T, Paus R, et al
    Protection of glucotoxicity by a tripeptide derivative of alpha-melanocyte-stimulating hormone in human epidermal keratinocytes.
    Br J Dermatol. 2018 Sep 1. doi: 10.1111/bjd.17125.
    PubMed     Text format     Abstract available


  176. SIMON M
    Effects of environmental skin stressors on filaggrin degradation products: importance for eczema.
    Br J Dermatol. 2018;179:560-561.
    PubMed     Text format    


  177. PASSI A
    Hyaluronan is a key regulator of skin homeostasis and wound healing.
    Br J Dermatol. 2018;179:558-559.
    PubMed     Text format    


  178. HAUG V, Schilling B
    Programmed death-1 blockade for multiple basal cell carcinomas: clearing the field systemically?
    Br J Dermatol. 2018;179:566-567.
    PubMed     Text format    


  179. TOBIN DJ
    Early evidence for opposing effects of full versus fragmented adiponectin on melanogenesis in human epidermal melanocytes.
    Br J Dermatol. 2018;179:561-562.
    PubMed     Text format    


    August 2018
  180. LEONARDI C, Papp K, Strober B, Thaci D, et al
    Comprehensive Long-Term Safety of Adalimumab from Eighteen Clinical Trials in Adult Patients With Moderate to Severe Plaque Psoriasis.
    Br J Dermatol. 2018 Aug 31. doi: 10.1111/bjd.17084.
    PubMed     Text format     Abstract available


  181. LIU NF, Yu ZY, Lou Y, Sun D, et al
    A Milroy case with FLT4/VEGFR3 mutation and an unusual skin biopsy.
    Br J Dermatol. 2018 Aug 31. doi: 10.1111/bjd.17120.
    PubMed     Text format     Abstract available


  182. WARREN RB, Marsden A, Tomenson B, Mason KJ, et al
    Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study.
    Br J Dermatol. 2018 Aug 28. doi: 10.1111/bjd.16776.
    PubMed     Text format     Abstract available


  183. KOGUCHI-YOSHIOKA H, Watanabe R, Fujisawa Y, Ishitsuka Y, et al
    Skin resident memory T cell population is not effectively constructed in systemic sclerosis.
    Br J Dermatol. 2018 Aug 18. doi: 10.1111/bjd.17100.
    PubMed     Text format     Abstract available


  184. IGHANI A, Georgakopoulos JR, Shear NH, Walsh S, et al
    Long-term 52-week trends in apremilast safety outcomes for treatment of psoriasis in clinical practice: a multicentre, retrospective case series.
    Br J Dermatol. 2018 Aug 18. doi: 10.1111/bjd.17099.
    PubMed     Text format     Abstract available


  185. GROOT J, Nybo Andersen AM, Adam A, Tind Nielsen TE, et al
    Associations between maternal socioeconomic position and psoriasis: A cohort study among the offspring of the Danish National Birth Cohort.
    Br J Dermatol. 2018 Aug 16. doi: 10.1111/bjd.17091.
    PubMed     Text format     Abstract available


  186. NAVASIOLAVA N, Gnanou M, Douillard M, Saulnier P, et al
    The Extent of PXE Skin Changes is Related to Cardiovascular Complications and Visual Loss: a Cross-sectional Study.
    Br J Dermatol. 2018 Aug 16. doi: 10.1111/bjd.17094.
    PubMed     Text format     Abstract available


  187. FOGARTY GB, McLaren KR, Moutrie Z, Poon TSC, et al
    Locally advanced skin cancers of the frail and elderly - consider adaptive split course radiotherapy (ASCRT).
    Br J Dermatol. 2018 Aug 16. doi: 10.1111/bjd.17037.
    PubMed     Text format     Abstract available


  188. HUET F, Dion A, Batardiere A, Nedelec AS, et al
    Sensitive skin can be small fiber neuropathy: Results from a case-control quantitative sensory testing study.
    Br J Dermatol. 2018 Aug 16. doi: 10.1111/bjd.17082.
    PubMed     Text format     Abstract available


  189. WATSON N, Wu K, Farr P, Reynolds N, et al
    Ustekinumab Exposure during Conception and Pregnancy in Patients with Chronic Plaque Psoriasis - a case series of 10 pregnancies.
    Br J Dermatol. 2018 Aug 13. doi: 10.1111/bjd.17086.
    PubMed     Text format     Abstract available


  190. CUST AE, Aitken J, Baade P, Whiteman D, et al
    Why a randomised melanoma screening trial may be a good idea.
    Br J Dermatol. 2018 Aug 13. doi: 10.1111/bjd.17089.
    PubMed     Text format     Abstract available


  191. FERTITTA L, Sicre de Fontbrune F, Battistella M, De Masson A, et al
    Folliculotropic Mycosis fungoides associated with GATA2 deficiency: a new skin manifestation.
    Br J Dermatol. 2018 Aug 12. doi: 10.1111/bjd.17081.
    PubMed     Text format     Abstract available


  192. CLASSEN A, Buhl T, Schubert S, Worm M, et al
    The frequency of specific contact allergies is reduced in psoriasis patients.
    Br J Dermatol. 2018 Aug 12. doi: 10.1111/bjd.17080.
    PubMed     Text format     Abstract available


  193. TSAI TY, Yen H, Huang YC
    Serum homocysteine, folate, and vitamin B12 levels in patients with psoriasis: A systematic review and meta-analysis.
    Br J Dermatol. 2018 Aug 3. doi: 10.1111/bjd.17034.
    PubMed     Text format     Abstract available


  194. YIU ZZN, Ashcroft DM, Evans I, McElhone K, et al
    Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the United Kingdom and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
    Br J Dermatol. 2018 Aug 2. doi: 10.1111/bjd.17036.
    PubMed     Text format     Abstract available


  195. CLAUSEN ML, Edslev SM, Norreslet LB, Sorensen JA, et al
    Temporal Variation of Staphylococcus aureus clonal complexes in Atopic Dermatitis - a follow up study.
    Br J Dermatol. 2018 Aug 2. doi: 10.1111/bjd.17033.
    PubMed     Text format     Abstract available


  196. THOMAS KS
    Could we be doing more to provide an evidence base for rare skin conditions?
    Br J Dermatol. 2018;179:240-241.
    PubMed     Text format    


  197. PROKSCH E
    Lowering skin pH: improved barrier function, anti-ageing and beyond.
    Br J Dermatol. 2018;179:254-255.
    PubMed     Text format    


  198. GJERSVIK P
    Biologics: targeting systemic inflammation in psoriasis.
    Br J Dermatol. 2018;179:247-248.
    PubMed     Text format    


  199. TOWER RL
    Kaposiform haemangioendothelioma: new insights and old problems.
    Br J Dermatol. 2018;179:253-254.
    PubMed     Text format    


  200. MONTGOMERY K, Thompson AR
    Developing sensitivity to the psychological burden associated with skin conditions: a call for training.
    Br J Dermatol. 2018;179:237-238.
    PubMed     Text format    


  201. VAN DOORN R
    Methylation marks melanoma metastasis.
    Br J Dermatol. 2018;179:250-251.
    PubMed     Text format    


  202. THYSSEN JP
    The trade-off: evolutionary benefits of epidermal filaggrin deficiency on cheek skin came at the price of the atopic dermatitis epidemic.
    Br J Dermatol. 2018;179:235-236.
    PubMed     Text format    


  203. WALSH S, Creamer D
    Severe cutaneous adverse reactions syndromes and prescribing autonomy.
    Br J Dermatol. 2018;179:242-243.
    PubMed     Text format    


  204. CAHOON EK
    Repurposing clinical trial data for skin cancer aetiology.
    Br J Dermatol. 2018;179:243-244.
    PubMed     Text format    


  205. MELLODY KT, Horn J, Watson REB
    Heterogenity of dermal fibroblasts: skin equivalent models that aim to recreate the cutaneous microenvironment.
    Br J Dermatol. 2018;179:248-250.
    PubMed     Text format    


  206. KIRBY B, Lynch M
    Adipokines and psoriasis: the obesity link.
    Br J Dermatol. 2018;179:239.
    PubMed     Text format    


    July 2018
  207. KUSHNER CJ, Tarazi M, Gaffney RG, Feng R, et al
    Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in pediatric cutaneous lupus among pediatric dermatologists and rheumatologists.
    Br J Dermatol. 2018 Jul 23. doi: 10.1111/bjd.17012.
    PubMed     Text format     Abstract available


  208. KANZAKI A, Kato Y, Kariya T, Kanda Y, et al
    Basal cell carcinoma response to imiquimod was associated with the Gli1/Gli3 expression ratio.
    Br J Dermatol. 2018 Jul 17. doi: 10.1111/bjd.17015.
    PubMed     Text format     Abstract available


  209. POLUBOTHU S, Glover M, Holder SE, Kinsler VA, et al
    Uniparental disomy as a mechanism for CERS3-mutated autosomal recessive congenital ichthyosis.
    Br J Dermatol. 2018 Jul 14. doi: 10.1111/bjd.16999.
    PubMed     Text format     Abstract available


  210. PARISI R, Webb RT, Kleyn CE, Carr MJ, et al
    Psychiatric morbidity and suicidal behaviour in psoriasis: a primary care cohort study.
    Br J Dermatol. 2018 Jul 14. doi: 10.1111/bjd.17004.
    PubMed     Text format     Abstract available


  211. CONNOLLY A, Grandi V, Stefanato CM, Palmer R, et al
    Primary cutaneous CD30(+) anaplastic large cell lymphoma associated with fingolimod.
    Br J Dermatol. 2018 Jul 14. doi: 10.1111/bjd.17003.
    PubMed     Text format     Abstract available


  212. PAPIER K, Gordon LG, Khosrotehrani K, Isbel N, et al
    Management of organ transplant recipients attending a high-throughput skin cancer surgery and surveillance clinic in Queensland.
    Br J Dermatol. 2018 Jul 13. doi: 10.1111/bjd.17001.
    PubMed     Text format     Abstract available


  213. HULSHOF L, Hack DP, Hasnoe QCJ, Dontje B, et al
    Stratum corneum analysis provide a minimal invasive tool to study immune response and skin barrier in atopic dermatitis children.
    Br J Dermatol. 2018 Jul 10. doi: 10.1111/bjd.16994.
    PubMed     Text format     Abstract available


  214. CHIJIWA C, Takeoka S, Kamata M, Uchida H, et al
    Secukinumab decreases the serum KL-6 level in psoriasis patients with elevated serum KL-6 level.
    Br J Dermatol. 2018 Jul 9. doi: 10.1111/bjd.16993.
    PubMed     Text format     Abstract available


  215. THYSSEN JP, Egeberg A
    Cardiovascular disease and atopic dermatitis: epidemiological strengths and limitations.
    Br J Dermatol. 2018 Jul 3. doi: 10.1111/bjd.16939.
    PubMed     Text format     Abstract available


  216. TSAKOK T, Woolf R, Smith CH, Weidinger S, et al
    Atopic dermatitis: the skin barrier and beyond.
    Br J Dermatol. 2018 Jul 3. doi: 10.1111/bjd.16934.
    PubMed     Text format     Abstract available


  217. RENCZ F, Gulacsi L, Pentek M, Poor AK, et al
    Proposal of a new scoring formula for the DLQI in psoriasis.
    Br J Dermatol. 2018 Jul 1. doi: 10.1111/bjd.16927.
    PubMed     Text format     Abstract available


  218. BRANDWEIN M, Fuks G, Israel A, Nejman D, et al
    Identification of a unique Staphylococcus aureus ribosomal signature in severe atopic dermatitis.
    Br J Dermatol. 2018 Jul 1. doi: 10.1111/bjd.16936.
    PubMed     Text format     Abstract available


  219. GUNN DA
    Histone H3 acetylation is a conduit of gene expression perturbations in photodamaged skin.
    Br J Dermatol. 2018;179:10-11.
    PubMed     Text format    


  220. GISONDI P
    The multidimensional burden of psoriasis.
    Br J Dermatol. 2018;179:13-14.
    PubMed     Text format    


  221. MAYBURY CM, Di Meglio P, Smith CH
    Aldara-induced dermatitis is associated with development of liver fibrosis in mice.
    Br J Dermatol. 2018;179:9-10.
    PubMed     Text format    


  222. POWELL J, Badminton M
    Shedding light on recent advances in our understanding of cutaneous porphyrias.
    Br J Dermatol. 2018;179:1-2.
    PubMed     Text format    


  223. NOBILI V
    Liver-skin axis: a new view or viewed already?
    Br J Dermatol. 2018;179:6.
    PubMed     Text format    


    June 2018
  224. AHLSTROM MG, Thyssen JP, Menne T, Midander K, et al
    Short contact with nickel causes allergic contact dermatitis: an experimental study.
    Br J Dermatol. 2018 Jun 29. doi: 10.1111/bjd.16935.
    PubMed     Text format     Abstract available


  225. ZHAO J, Zhang X, Sun H, An R, et al
    Is psoriasis a risk factor of angiography-proven coronary artery disease?
    Br J Dermatol. 2018 Jun 29. doi: 10.1111/bjd.16925.
    PubMed     Text format     Abstract available


  226. JOLY-TONETTI N, Wibawa JID, Bell M, Tobin DJ, et al
    An explanation for the mysterious distribution of melanin in human skin - a rare example of asymmetric (melanin) organelle distribution during mitosis of basal layer progenitor keratinocytes.
    Br J Dermatol. 2018 Jun 29. doi: 10.1111/bjd.16926.
    PubMed     Text format     Abstract available


  227. FUJISAWA Y, Otomo Y, Ogata Y, Nakamura Y, et al
    Deep learning-based, computer-aided classifier developed with a small dataset of clinical images surpasses board-certified dermatologists in skin tumor diagnosis.
    Br J Dermatol. 2018 Jun 28. doi: 10.1111/bjd.16924.
    PubMed     Text format     Abstract available


  228. HARMS FL, Nampoothiri S, Kortum F, Thomas J, et al
    Coinheritance of biallelic SLURP1 and SLC39A4 mutations cause a severe genodermatosis with skin peeling and hair loss all over the body.
    Br J Dermatol. 2018 Jun 27. doi: 10.1111/bjd.16912.
    PubMed     Text format     Abstract available


  229. SKOV L, Thomsen SF, Kristensen LE, Dodge R, et al
    Cause-specific mortality in patients with psoriasis and psoriatic arthritis.
    Br J Dermatol. 2018 Jun 27. doi: 10.1111/bjd.16919.
    PubMed     Text format     Abstract available


  230. MOCHIZUKI H, Lavery MJ, Nattkemper LA, Albornoz C, et al
    Impact of Acute Stress on Itch Sensation and Scratching Behavior in Atopic Dermatitis Patients and Healthy Controls.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16921.
    PubMed     Text format     Abstract available


  231. KALAKI E, Mizara A
    The role of parenting experiences, rather than age of onset or presence of the skin condition, in the development of maladaptive schemas in a community sample of patients with atopic dermatitis.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16920.
    PubMed     Text format     Abstract available


  232. HURAULT G, Schram ME, Roekevisch E, Spuls PI, et al
    Relationship and probabilistic stratification of EASI and oSCORAD severity scores for atopic dermatitis.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16916.
    PubMed     Text format     Abstract available


  233. HABJANIC N, Koytchev R, Yankova R, Kerec-Kos M, et al
    Therapeutic equivalence of two formulations of calcipotriol-betamethasone ointment: a multi-centre, randomized, double-blind study in adult patients with chronic plaque psoriasis.
    Br J Dermatol. 2018 Jun 26. doi: 10.1111/bjd.16913.
    PubMed     Text format     Abstract available


  234. TINA E, Prosen S, Lennholm S, Gasparyan G, et al
    Expression profile of the amino acid transporters SLC7A5, SLC7A7, SLC7A8 and the enzyme TDO2 in basal cell carcinoma.
    Br J Dermatol. 2018 Jun 25. doi: 10.1111/bjd.16905.
    PubMed     Text format     Abstract available


  235. GOUSSOT R, Frances C, Cury K, Bessis D, et al
    Prospective evaluation of frequency of genital lichen sclerosus in 79 patients with systemic sclerosis.
    Br J Dermatol. 2018 Jun 21. doi: 10.1111/bjd.16898.
    PubMed     Text format     Abstract available


  236. VAN EGMOND S, Wakkee M, Droger M, Bastiaens MT, et al
    Needs and preferences of patients regarding basal cell carcinoma and cutaneous squamous cell carcinoma care: a qualitative focus group study.
    Br J Dermatol. 2018 Jun 21. doi: 10.1111/bjd.16900.
    PubMed     Text format     Abstract available


  237. WARREN RB, Reich K, Langley RG, Strober B, et al
    Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database.
    Br J Dermatol. 2018 Jun 21. doi: 10.1111/bjd.16901.
    PubMed     Text format     Abstract available


  238. NARANG T, Kumar S, Handa S, Dogra S, et al
    Hydroxyurea and Acitretin as a novel combination therapy in severe plaque psoriasis.
    Br J Dermatol. 2018 Jun 21. doi: 10.1111/bjd.16899.
    PubMed     Text format     Abstract available


  239. EATON LH, Dearman RJ, Kimber I, Griffiths CEM, et al
    Keratinocytes derived from late-onset psoriasis skin do not impair Langerhans cell migration.
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16896.
    PubMed     Text format     Abstract available


  240. KEOHANE SG, Proby CM, Newlands C, Motley RJ, et al
    The new 8th edition of TNM staging and its implications for skin cancer: a review by the British Association of Dermatologists and the Royal College of Pathologists, United Kingdom.
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16892.
    PubMed     Text format     Abstract available


  241. VAN DER LINDEN M, Schuurman MS, Bulten J, Massuger LFAG, et al
    Stop routine screening for associated malignancies in cutaneous non-invasive vulvar Paget disease?
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16894.
    PubMed     Text format     Abstract available


  242. DRUCKER AM, Flohr C
    Revisiting atopic dermatitis and cardiovascular disease.
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16891.
    PubMed     Text format     Abstract available


  243. BLAUVELT A, Lacour JP, Fowler JF Jr, Weinberg JM, et al
    Phase 3 randomised study of the proposed biosimilar adalimumab GP2017 in psoriasis - impact of multiple switches.
    Br J Dermatol. 2018 Jun 19. doi: 10.1111/bjd.16890.
    PubMed     Text format     Abstract available


  244. BOSWELL K, Cameron H, West J, Fleming C, et al
    Narrowband-UVB treatment for psoriasis is highly economical and causes significant savings in cost for topical treatments.
    Br J Dermatol. 2018 Jun 14. doi: 10.1111/bjd.16716.
    PubMed     Text format     Abstract available


  245. FUJISAWA Y, Otomo Y, Ogata Y, Nakamura Y, et al
    Deep learning-based, computer-aided classifier developed with a small dataset of clinical images surpasses board-certified dermatologists in skin tumor diagnosis.
    Br J Dermatol. 2018 Jun 14. doi: 10.1111/bjd.16826.
    PubMed     Text format     Abstract available


  246. SNEKVIK I, Nilsen TIL, Romundstad PR, Saunes M, et al
    Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway.
    Br J Dermatol. 2018 Jun 14. doi: 10.1111/bjd.16885.
    PubMed     Text format     Abstract available


  247. FARAH M, Nagarajan P, Curry JL, Tang Z, et al
    Spitzoid melanoma with histopathologic features of ALK gene rearrangement exhibiting ALK copy number gain: A novel mechanism of ALK activation in spitzoid neoplasia.
    Br J Dermatol. 2018 Jun 13. doi: 10.1111/bjd.16881.
    PubMed     Text format     Abstract available


  248. HALVORSEN JA, Loberg M, Gjersvik P, Roscher I, et al
    Why a randomized melanoma screening trial is not a good idea.
    Br J Dermatol. 2018 Jun 12. doi: 10.1111/bjd.16784.
    PubMed     Text format    


  249. COLLIER NJ, Haylett AK, Wong TH, Morton CA, et al
    Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis.
    Br J Dermatol. 2018 Jun 11. doi: 10.1111/bjd.16838.
    PubMed     Text format     Abstract available


  250. HESSELVIG JH, Egeberg A, Kofoed K, Gislason G, et al
    Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study.
    Br J Dermatol. 2018 Jun 9. doi: 10.1111/bjd.16831.
    PubMed     Text format     Abstract available


  251. PAPIER K, Gordon LG, Khosrotehrani K, Isbel N, et al
    Increase in preventive behaviour by organ transplant recipients after sun protection information in a skin cancer surveillance clinic.
    Br J Dermatol. 2018 Jun 8. doi: 10.1111/bjd.16836.
    PubMed     Text format     Abstract available


  252. FAVRE B, Begre N, Borradori L
    A recessive mutation in the DSP gene linked to cardiomyopathy, skin fragility and hair defects impairs the binding of desmoplakin to epidermal keratins and the muscle-specific intermediate filament desmin.
    Br J Dermatol. 2018 Jun 7. doi: 10.1111/bjd.16832.
    PubMed     Text format     Abstract available


  253. PODLIPNIK S, Moreno-Ramirez D, Carrera C, Barreiro A, et al
    Cost-effectiveness analysis of imaging strategy for an intensive follow-up of patients with AJCC stage IIB, IIC and III malignant melanoma.
    Br J Dermatol. 2018 Jun 7. doi: 10.1111/bjd.16833.
    PubMed     Text format     Abstract available


  254. MIOLA AC, Roio EF, Lima TRR, Schmitt JV, et al
    Effectiveness and safety of 0.5% colchicine cream versus photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis and skin field cancerisation of the forearms: a randomized controlled trial.
    Br J Dermatol. 2018 Jun 3. doi: 10.1111/bjd.16824.
    PubMed     Text format     Abstract available


  255. STENEHJEM JS, Veierod MB, Nilsen LT, Ghiasvand R, et al
    Anthropometric factors and Breslow thickness: Prospective data on 2570 cutaneous melanoma cases in the population-based Janus Cohort.
    Br J Dermatol. 2018 Jun 1. doi: 10.1111/bjd.16825.
    PubMed     Text format     Abstract available


  256. VON KOBYLETZKI LB, Svensson A
    Building the evidence base for current systemic treatments for severe, chronic atopic dermatitis: methotrexate vs. azathioprine.
    Br J Dermatol. 2018;178:1236-1237.
    PubMed     Text format    


  257. KIM Y, Kraft P, Asgari MM
    Using a Mendelian randomization approach to explore a causal relationship between vitamin D and nonmelanoma skin cancer.
    Br J Dermatol. 2018;178:1241-1242.
    PubMed     Text format    


  258. SEDDON O, Hughes H
    Staphylococcus aureus and atopic dermatitis: a complex relationship.
    Br J Dermatol. 2018;178:1234.
    PubMed     Text format    


  259. YU H, Li R, Yue Y, Li A, et al
    Image Gallery: Skin lesions from jellyfish stings.
    Br J Dermatol. 2018;178:e393.
    PubMed     Text format    


  260. KIRBY B
    Langerhans cells in psoriasis: getting to the core of the disease.
    Br J Dermatol. 2018;178:1240.
    PubMed     Text format    


  261. OFENLOCH RF
    Incontinence-associated dermatitis: a consensus on its severity assessment.
    Br J Dermatol. 2018;178:1238-1239.
    PubMed     Text format    


  262. DRUCKER AM, Flohr C
    Atopic dermatitis and cardiovascular disease: have we seen enough to refute a causal link?
    Br J Dermatol. 2018;178:1235-1236.
    PubMed     Text format    


  263. BALIEVA F
    Psoriasis has a huge impact on teenagers.
    Br J Dermatol. 2018;178:1243.
    PubMed     Text format    


    May 2018
  264. GONNET J, Perrin H, Hutton AJ, Boccara D, et al
    Interleukin-32 promotes detachment and activation of human Langerhans cells in a human skin explant model.
    Br J Dermatol. 2018 May 28. doi: 10.1111/bjd.16721.
    PubMed     Text format     Abstract available


  265. LIN YK, Lee BH
    Does Lindioil (Indirubin) treatment affect the composition of Malassezia species on psoriatic skin?
    Br J Dermatol. 2018 May 23. doi: 10.1111/bjd.16810.
    PubMed     Text format     Abstract available


  266. SBIDIAN E, Mezzarobba M, Weill A, Coste J, et al
    Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16,545 biologic-naive patients from the French national health insurance database (SNIIRAM).
    Br J Dermatol. 2018 May 23. doi: 10.1111/bjd.16809.
    PubMed     Text format     Abstract available


  267. GAITANIS G, Magiatis P, Velegraki A, Bassukas ID, et al
    A traditional Chinese remedy points to a natural skin habitat: Indirubin (indigo naturalis) for psoriasis and the Malassezia metabolome.
    Br J Dermatol. 2018 May 23. doi: 10.1111/bjd.16807.
    PubMed     Text format     Abstract available


  268. VALENZUELA F, Korman NJ, Bissonnette R, Bakos N, et al
    Tofacitinib in patients with moderate to severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study.
    Br J Dermatol. 2018 May 21. doi: 10.1111/bjd.16798.
    PubMed     Text format     Abstract available


  269. BRUNET-POSSENTI F, Charpentier C, Collin G, Descamps D, et al
    Impact of anti-IL-17 treatment on cutaneous and genital HPV infection.
    Br J Dermatol. 2018 May 19. doi: 10.1111/bjd.16799.
    PubMed     Text format     Abstract available


  270. WAN MT, Ming ME
    Nivolumab versus ipilimumab in the treatment of advanced melanoma: a critical appraisal.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16785.
    PubMed     Text format     Abstract available


  271. CHRISTENSEN L, Cooper K, Honda K, Mansur D, et al
    Relapse rates in patients with unilesional primary cutaneous B cell lymphoma treated with radiation therapy: a single-institution experience.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16783.
    PubMed     Text format     Abstract available


  272. ZHU TH, Zhu TR, Tran KA, Sivamani RK, et al
    Epithelial Barrier Dysfunctions in Atopic Dermatitis: A Skin-Gut-Lung Model Linking Microbiome Alteration and Immune Dysregulation.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16734.
    PubMed     Text format     Abstract available


  273. CAYUELA A, Cayuela L, Rodriguez-Dominguez S, Lorente AI, et al
    Is melanoma mortality declining in Spain? Analysis of trends 1975-2016.
    Br J Dermatol. 2018 May 14. doi: 10.1111/bjd.16777.
    PubMed     Text format     Abstract available


  274. PILKINGTON SM, Dearman RJ, Kimber I, Griffiths CEM, et al
    Langerhans cells express human beta defensin-3: relevance for immunity during skin ageing.
    Br J Dermatol. 2018 May 14. doi: 10.1111/bjd.16770.
    PubMed     Text format     Abstract available


  275. GOLBARI NM, Lockwood SJ, Porter ML, Kimball AB, et al
    Assessment of Treatment-Seeking Behaviour in Patients with Psoriasis.
    Br J Dermatol. 2018 May 14. doi: 10.1111/bjd.16778.
    PubMed     Text format     Abstract available


  276. MOAWAD S, Reigneau M, de la Fouchardiere A, Soufir N, et al
    Clinical, dermoscopic, histological and molecular analysis of BAP1 inactivated melanocytic nevus/tumor in two familial cases of BAP1 syndrome.
    Br J Dermatol. 2018 May 13. doi: 10.1111/bjd.16740.
    PubMed     Text format     Abstract available


  277. EL KHOURY M, Assier H, Gener G, Paul M, et al
    Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin, and pristinamycin: clinical history and patch testing.
    Br J Dermatol. 2018 May 10. doi: 10.1111/bjd.16738.
    PubMed     Text format     Abstract available


  278. RYAN C, Menter A, Guenther L, Blauvelt A, et al
    Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled Phase 3b Study of Patients with Moderate-to-Severe Genital Psoriasis.
    Br J Dermatol. 2018 May 10. doi: 10.1111/bjd.16736.
    PubMed     Text format     Abstract available


  279. KIMBALL AB, Augustin M, Gordon KB, Krueger GG, et al
    Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
    Br J Dermatol. 2018 May 10. doi: 10.1111/bjd.16737.
    PubMed     Text format     Abstract available


  280. BLAUVELT A, Reich K, Papp KA, Kimball AB, et al
    Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Three Randomised Controlled Trials.
    Br J Dermatol. 2018 May 9. doi: 10.1111/bjd.16724.
    PubMed     Text format     Abstract available


  281. WEHNER MR, Dalma N, Landefeld C, Pare-Anastasiadou A, et al
    Natural history of lesions suspicious for basal cell carcinoma in older adults in Ikaria, Greece.
    Br J Dermatol. 2018 May 9. doi: 10.1111/bjd.16730.
    PubMed     Text format     Abstract available


  282. FUJISAWA Y
    Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors: reply from the authors.
    Br J Dermatol. 2018 May 7. doi: 10.1111/bjd.16689.
    PubMed     Text format    


  283. HARKINS CP, McAleer MA, Bennett D, McHugh M, et al
    The widespread use of topical antimicrobials enriches for resistance in Staphylococcus aureus isolated from Atopic Dermatitis patients.
    Br J Dermatol. 2018 May 5. doi: 10.1111/bjd.16722.
    PubMed     Text format     Abstract available


  284. SU KA, Habel LA, Achacoso NS, Friedman GD, et al
    Photosensitizing Antihypertensive Drug Use and Risk of Cutaneous Squamous Cell Carcinoma.
    Br J Dermatol. 2018 May 3. doi: 10.1111/bjd.16713.
    PubMed     Text format     Abstract available


  285. GARCIA-DOVAL I, Descalzo MA, Mason KJ, Cohen AD, et al
    Cumulative exposure to biologics and risk of cancer in psoriasis patients: A meta-analysis of Psonet studies from Israel, Italy, Spain, United Kingdom and Republic of Ireland.
    Br J Dermatol. 2018 May 3. doi: 10.1111/bjd.16715.
    PubMed     Text format     Abstract available


  286. DODOO-SCHITTKO F
    Psoriasis: the significance of psychological stress.
    Br J Dermatol. 2018;178:1002.
    PubMed     Text format    


  287. ERGEN EN, Donaldson SL, Stratton MS, Pavlidakey PG, et al
    Image Gallery: Molluscum contagiosum-like facial lesions in a patient with a renal transplant: deep dermatophytosis due to Trichophyton rubrum.
    Br J Dermatol. 2018;178:e328.
    PubMed     Text format    


  288. GOMEZ MOYANO E, Vera-Casano A, Ayala-Blanca M, Martinez-Pilar L, et al
    Image Gallery: Cutaneous findings in Hunter syndrome.
    Br J Dermatol. 2018;178:e329.
    PubMed     Text format    


  289. KRAEMER KH, Tamura D, Khan SG
    Pembrolizumab treatment of a patient with xeroderma pigmentosum with disseminated melanoma and multiple nonmelanoma skin cancers.
    Br J Dermatol. 2018;178:1009.
    PubMed     Text format    


  290. ROSSI AM, Navarrete-Dechent C, Nehal KS
    Beyond skin deep: taking bedside dermatology to the next level with noninvasive technologies.
    Br J Dermatol. 2018;178:994-996.
    PubMed     Text format    


  291. LI BS, Cary JH, Maibach HI
    Cutaneous biometrics: guidelines and models.
    Br J Dermatol. 2018;178:1008-1009.
    PubMed     Text format    


  292. BRAY N, Wolf P
    Allocation of biologics: health economics and clinical decision making in plaque psoriasis.
    Br J Dermatol. 2018;178:997-998.
    PubMed     Text format    


  293. DARRIGADE AS, Boniface K, Seneschal J
    Inflammatory skin eruptions induced by anti-tumour necrosis factor-alpha therapy differ undeniably from psoriasis or eczema.
    Br J Dermatol. 2018;178:1007-1008.
    PubMed     Text format    


  294. PAUL C
    Ixekizumab or secukinumab in psoriasis: what difference does it make?
    Br J Dermatol. 2018;178:1003-1005.
    PubMed     Text format    


  295. SCHALKWIJK J
    A role for the microbiome in psoriasis?
    Br J Dermatol. 2018;178:999-1000.
    PubMed     Text format    


  296. SCHMITT J
    After the approval of dupilumab for moderate-to-severe atopic dermatitis: what is next on the research agenda?
    Br J Dermatol. 2018;178:992-993.
    PubMed     Text format    


    April 2018
  297. DARRIGADE AS, Legrand A, Andreu N, Jacquemin C, et al
    Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata.
    Br J Dermatol. 2018 Apr 30. doi: 10.1111/bjd.16711.
    PubMed     Text format     Abstract available


  298. MIYAZAWA H, Fujita Y, Iwata H, Ishikawa Y, et al
    Two cases of generalized pustular psoriasis complicated with IgG4-related disease.
    Br J Dermatol. 2018 Apr 30. doi: 10.1111/bjd.16712.
    PubMed     Text format     Abstract available


  299. TETU P, Monfort JB, Barbaud A, Frances C, et al
    Failure of Rituximab in refractory erosive lichen planus.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16704.
    PubMed     Text format     Abstract available


  300. BAN L, Labbouz S, Grindlay D, Batchelor J, et al
    Risk of skin cancer in people with vitiligo: a systematic review and meta-analysis.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16703.
    PubMed     Text format     Abstract available


  301. WANG R, Song Y, Du M, Yang E, et al
    Skin microbiome changes in patients with interdigital tinea pedis.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16706.
    PubMed     Text format     Abstract available


  302. RAUWERDINK DJW, Roach REJ, Etty M, Kukutsch NA, et al
    Melanoma diagnosis during periodic surveillance of patients with multiple atypical naevi.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16708.
    PubMed     Text format     Abstract available


  303. COSTANZO A, Bianchi L, Flori ML, Malara G, et al
    Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16705.
    PubMed     Text format     Abstract available


  304. JENSEN P, Zachariae C, Skov L, Zachariae R, et al
    Sleep disturbance in psoriasis - a case-controlled study.
    Br J Dermatol. 2018 Apr 28. doi: 10.1111/bjd.16702.
    PubMed     Text format     Abstract available


  305. FOO SH, Nightingale PG, Gazzani P, Bader E, et al
    A 10 year longitudinal follow up study of a UK paediatric transplant population to assess for skin cancer.
    Br J Dermatol. 2018 Apr 27. doi: 10.1111/bjd.16697.
    PubMed     Text format     Abstract available


  306. MCALEER MA, Jakasa I, Raj N, O'Donnell CPF, et al
    Early life regional and temporal variation in filaggrin-derived natural moisturising factor, filaggrin processing enzyme activity, corneocyte phenotypes and plasmin activity: Implications for atopic dermatitis.
    Br J Dermatol. 2018 Apr 25. doi: 10.1111/bjd.16691.
    PubMed     Text format     Abstract available


  307. NARBUTT J, Philipsen PA, Lesiak A, Liljendahl TS, et al
    Children sustain high levels of skin DNA photodamage, with a modest increase of serum 25(OH)D3 , after a summer holiday in Northern Europe.
    Br J Dermatol. 2018 Apr 24. doi: 10.1111/bjd.16668.
    PubMed     Text format     Abstract available


  308. CHALMERS JR, Thomas KS, Apfelbacher C, Williams HC, et al
    Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
    Br J Dermatol. 2018 Apr 19. doi: 10.1111/bjd.16543.
    PubMed     Text format     Abstract available


  309. EGEBERG A, Skov L
    Drug survival of secukinumab for moderate-to-severe plaque psoriasis: reply from authors.
    Br J Dermatol. 2018 Apr 19. doi: 10.1111/bjd.16690.
    PubMed     Text format    


  310. FUJIMURA T, Sato Y, Kambayashi Y, Tanita K, et al
    Three cases of advanced cutaneous angiosarcoma treated with eribulin: investigation of serum soluble CD163 and CXCL10 as possible biomarkers predicting the biological behaviour of angiosarcoma.
    Br J Dermatol. 2018 Apr 17. doi: 10.1111/bjd.16676.
    PubMed     Text format     Abstract available


  311. LANGAN EA, Gratz V, Billmann F, Zillikens D, et al
    Does the gastrointestinal microbiome contribute to the "obesity paradox" in melanoma survival?
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16681.
    PubMed     Text format     Abstract available


  312. CARLAVAN I, Bertino B, Rivier M, Martel P, et al
    Atrophic scar formation in acne patients involves long-acting immune responses with plasma cells and alteration of sebaceous glands.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16680.
    PubMed     Text format     Abstract available


  313. KIM J, Kim YH, Park B, Seo HM, et al
    Multispectral ex vivo photoacoustic imaging of cutaneous melanoma for better selection of the excision margin.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16677.
    PubMed     Text format     Abstract available


  314. VARMA S
    Frequency of squamous cell carcinoma in situ (SCCIS) and SCC in re-excisions of biopsy-proven cutaneous SCCIS.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16674.
    PubMed     Text format     Abstract available


  315. MACHET L, Zaragoza J, Finon A, Garnier M, et al
    Baseline neutrophil to lymphocyte ratio in patients with advanced melanoma treated with immune check point inhibitors.
    Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16675.
    PubMed     Text format     Abstract available


  316. LEE EH, Klassen AF, Cano SJ, Nehal KS, et al
    FACE-Q Skin Cancer Module for Measuring Patient-Reported Outcomes Following Facial Skin Cancer Surgery.
    Br J Dermatol. 2018 Apr 14. doi: 10.1111/bjd.16671.
    PubMed     Text format     Abstract available


  317. SVENDSEN MT, Andersen F, Andersen KH, Pottegard A, et al
    An App Supporting Psoriasis Patients Improves Adherence to Topical Treatment: A randomised controlled trial.
    Br J Dermatol. 2018 Apr 14. doi: 10.1111/bjd.16667.
    PubMed     Text format     Abstract available


  318. MCNOE BM, Reeder AI, de Lange MP
    SunSmart schools: a New Zealand skin cancer primary prevention intervention blueprint for primary school settings.
    Br J Dermatol. 2018 Apr 14. doi: 10.1111/bjd.16670.
    PubMed     Text format     Abstract available


  319. GAN Y, Zhou M, He C, Chen Z, et al
    Lipidomics reveals skin surface lipid abnormity in male youth acne.
    Br J Dermatol. 2018 Apr 6. doi: 10.1111/bjd.16655.
    PubMed     Text format     Abstract available


  320. MENSA E, Recchioni R, Marcheselli F, Giuliodori K, et al
    MiR-146a-5p correlates with clinical efficacy in psoriasis patients treated with the TNF alpha inhibitor Adalimumab.
    Br J Dermatol. 2018 Apr 6. doi: 10.1111/bjd.16659.
    PubMed     Text format     Abstract available


  321. THOMPSON AR, Montgomery K
    Stress and more stress: the importance in skin disease of worrying about what others think.
    Br J Dermatol. 2018;178:821-822.
    PubMed     Text format    


  322. OOSTERHAVEN JAF
    Interpretability in atopic dermatitis: all about the anchor.
    Br J Dermatol. 2018;178:832-833.
    PubMed     Text format    


  323. APFELBACHER C
    The Cochrane Skin Group's COUSIN convened for the second time.
    Br J Dermatol. 2018;178:837-838.
    PubMed     Text format    


  324. AKEL R, Fuller C
    Updates in lichen sclerosis: British Association of Dermatologists guidelines for the management of lichen sclerosus 2018.
    Br J Dermatol. 2018;178:823-824.
    PubMed     Text format    


  325. BORRONI RG, Costanzo A
    HLA-C*06 and psoriasis: susceptibility, phenotype, course and response to treatment.
    Br J Dermatol. 2018;178:825.
    PubMed     Text format    


  326. HAAS L, Wiesner T, Obenauf AC
    A new era of proactive melanoma therapy: hit hard, hit early.
    Br J Dermatol. 2018;178:817-820.
    PubMed     Text format    


  327. KEZIC S
    Atopic dermatitis: risk estimates for hand eczema.
    Br J Dermatol. 2018;178:827.
    PubMed     Text format    


  328. MROWIETZ U
    Psoriasis, stress, age and more.
    Br J Dermatol. 2018;178:830-831.
    PubMed     Text format    


    March 2018
  329. JI Y, Yang K, Peng S, Chen S, et al
    Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon.
    Br J Dermatol. 2018 Mar 30. doi: 10.1111/bjd.16601.
    PubMed     Text format     Abstract available


  330. ANGELOVA-FISCHER I, Fischer TW, Abels C, Zillikens D, et al
    Accelerated barrier recovery and enhancement of the barrier integrity and properties by topical application of a pH 4 compared to a pH 5.8 w/o emulsion in aged skin.
    Br J Dermatol. 2018 Mar 25. doi: 10.1111/bjd.16591.
    PubMed     Text format     Abstract available


  331. VU M, Adler NR, Wee E, Wolfe R, et al
    Impact of naevus association on survival for nodular and superficial spreading melanomas.
    Br J Dermatol. 2018 Mar 24. doi: 10.1111/bjd.16556.
    PubMed     Text format     Abstract available


  332. MAHEVAS T, Bertinchamp R, Battistella M, Reygagne P, et al
    Efficacy of oral sirolimus as salvage therapy in refractory lichen planus associated with immune deficiency.
    Br J Dermatol. 2018 Mar 24. doi: 10.1111/bjd.16555.
    PubMed     Text format     Abstract available


  333. YAN K, Xu W, Huang Y, Zhang Z, et al
    Methotrexate restores the function of peripheral blood Treg cells in psoriasis vulgaris via CD73/AMPK/mTOR pathway.
    Br J Dermatol. 2018 Mar 23. doi: 10.1111/bjd.16560.
    PubMed     Text format     Abstract available


  334. PASSARELLI MN, Barry EL, Zhang D, Gangar P, et al
    Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.
    Br J Dermatol. 2018 Mar 23. doi: 10.1111/bjd.16571.
    PubMed     Text format     Abstract available


  335. LEE EB, Reynolds KA, Pithadia DJ, Wu JJ, et al
    Drug survival of secukinumab for moderate-to-severe plaque psoriasis.
    Br J Dermatol. 2018 Mar 23. doi: 10.1111/bjd.16572.
    PubMed     Text format     Abstract available


  336. FORSCHNER A, Keim U, Hofmann M, Spankuch I, et al
    Diagnostic accuracy of dermatofluoroscopy in cutaneous melanoma detection: Results of a prospective multicentre clinical study in 476 pigmented lesions.
    Br J Dermatol. 2018 Mar 22. doi: 10.1111/bjd.16565.
    PubMed     Text format     Abstract available


  337. ADAN F, Crijns MB, Zandstra WSE, Bekkenk MW, et al
    Cumulative risk of skin tumours in patients with Lynch syndrome.
    Br J Dermatol. 2018 Mar 15. doi: 10.1111/bjd.16552.
    PubMed     Text format     Abstract available


  338. HANSEN PR, Isaksen JL, Jemec GB, Kanters JK, et al
    Pulmonary function in subjects with psoriasis: A cross-sectional population study.
    Br J Dermatol. 2018 Mar 11. doi: 10.1111/bjd.16539.
    PubMed     Text format     Abstract available


  339. HERNANDEZ-BREIJO B, Jurado T, Rodriguez-Martin E, Martinez-Feito A, et al
    Differential blood cellular profile in patients with moderate to severe psoriasis treated with classical systemic therapies: A step forward in personalised medicine.
    Br J Dermatol. 2018 Mar 11. doi: 10.1111/bjd.16537.
    PubMed     Text format     Abstract available


  340. SCHMITZ L, Gambichler T, Kost C, Gupta G, et al
    Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses.
    Br J Dermatol. 2018 Mar 11. doi: 10.1111/bjd.16536.
    PubMed     Text format     Abstract available


  341. PEDROSA AF, Lisboa C, Faria-Ramos I, Silva RM, et al
    Malassezia species retrieved from skin with pityriasis versicolor, seborrheic dermatitis and skin free of lesions: a comparison of two sampling methods.
    Br J Dermatol. 2018 Mar 5. doi: 10.1111/bjd.16521.
    PubMed     Text format     Abstract available


  342. KIM HJ, Bonciani D, Zeidi M, Pena SM, et al
    Itch in dermatomyositis: the role of increased skin interleukin-31.
    Br J Dermatol. 2018 Mar 1. doi: 10.1111/bjd.16498.
    PubMed     Text format     Abstract available


  343. MELCHERS RC, Willemze R, Bekkenk MW, de Haas ERM, et al
    Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: Report of the Dutch Cutaneous Lymphoma Group.
    Br J Dermatol. 2018 Mar 1. doi: 10.1111/bjd.16501.
    PubMed     Text format     Abstract available


  344. MARCHAND A, Tallet A, Collin C, Cormier B, et al
    A rare BRAF T599dup mutation conferring sensitivity to BRAF inhibitor in a patient with metastatic melanoma.
    Br J Dermatol. 2018 Mar 1. doi: 10.1111/bjd.16499.
    PubMed     Text format     Abstract available


  345. FLEMING P
    Ixekizumab and psoriasis: an important entry into the therapeutic landscape.
    Br J Dermatol. 2018;178:585-586.
    PubMed     Text format    


  346. CAPON F
    The heterogeneous mutational landscape of pustular psoriasis.
    Br J Dermatol. 2018;178:589-590.
    PubMed     Text format    


  347. NANDA A
    Spectrum of cutaneous manifestations among patients with GATA2 deficiency.
    Br J Dermatol. 2018;178:593-594.
    PubMed     Text format    


  348. ABUABARA K, Flohr C
    Is new better than tried and tested? Topical atopic dermatitis treatment in context.
    Br J Dermatol. 2018;178:583-584.
    PubMed     Text format    


  349. BOUWES BAVINCK JN, van Zuuren EJ
    Light on fumaric acid esters therapy for psoriasis.
    Br J Dermatol. 2018;178:586-587.
    PubMed     Text format    


  350. TSAI YC
    Image Gallery: Contact dermatitis resulting from tarantula-hair injury mimicking ischaemia: a case with dermoscopy follow-up.
    Br J Dermatol. 2018;178:e227.
    PubMed     Text format    


  351. BARRAGAN-ESTUDILLO ZF, Jesus-Silva MA, Chavez-Bourgeois MM, Brito J, et al
    Image Gallery: Transition pattern in acral melanoma.
    Br J Dermatol. 2018;178:e225.
    PubMed     Text format    


    February 2018
  352. PAPP KA, Gordon KB, Langley RG, Lebwohl MG, et al
    Impact of Previous Biologic Use on Efficacy and Safety of Brodalumab and Ustekinumab in Patients with Moderate-to-Severe Plaque Psoriasis: Integrated Analysis of AMAGINE-2 and AMAGINE-3.
    Br J Dermatol. 2018 Feb 28. doi: 10.1111/bjd.16464.
    PubMed     Text format     Abstract available


  353. KIM Y, Cho JY, Oh SW, Kang M, et al
    Globular adiponectin acts as a melanogenic signal in human epidermal melanocytes.
    Br J Dermatol. 2018 Feb 27. doi: 10.1111/bjd.16488.
    PubMed     Text format     Abstract available


  354. ENGEBRETSEN KA, Kezic S, Jakasa I, Hedengran A, et al
    Effect of atopic skin stressors on natural moisturizing factors and cytokines in healthy adult epidermis.
    Br J Dermatol. 2018 Feb 27. doi: 10.1111/bjd.16487.
    PubMed     Text format     Abstract available


  355. STROBEL SB, Safferling K, Lahrmann B, Hoffmann JH, et al
    Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients.
    Br J Dermatol. 2018 Feb 25. doi: 10.1111/bjd.16477.
    PubMed     Text format     Abstract available


  356. NARLA S, Silverberg JI
    Association between childhood atopic dermatitis, cutaneous, extracutaneous and systemic infections.
    Br J Dermatol. 2018 Feb 25. doi: 10.1111/bjd.16482.
    PubMed     Text format     Abstract available


  357. HUNTER HJA, Morsman E, Mellody KT, Ogden SK, et al
    Acute psychosocial stress downregulates N-Methyl-d-aspartate receptors (NMDAR) in healthy human skin.
    Br J Dermatol. 2018 Feb 16. doi: 10.1111/bjd.16466.
    PubMed     Text format     Abstract available


  358. ORLOWSKA D, Selman LE, Beynon T, Radcliffe E, et al
    "It's a traumatic illness, traumatic to witness." A qualitative study of the experiences of bereaved family caregivers of patients with cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Feb 16. doi: 10.1111/bjd.16447.
    PubMed     Text format     Abstract available


  359. KOTTNER J, Jacobi L, Hahnel E, Alam M, et al
    Core outcome sets in dermatology: report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative.
    Br J Dermatol. 2018 Feb 14. doi: 10.1111/bjd.16324.
    PubMed     Text format     Abstract available


  360. KYRIAKOU A, Patsatsi A, Sotiriadis D, Goulis DG, et al
    Effects of treatment for psoriasis on circulating levels of leptin, adiponectin and resistin: a systematic review and meta-analysis.
    Br J Dermatol. 2018 Feb 12. doi: 10.1111/bjd.16437.
    PubMed     Text format     Abstract available


  361. MORTON CA, Dominicus R, Radny P, Dirschka T, et al
    A randomized, multi-national, non-inferiority, phase III trial to evaluate the safety and efficacy of BF-200 ALA gel versus MAL cream in the treatment of non-aggressive basal cell carcinoma with photodynamic therapy (PDT).
    Br J Dermatol. 2018 Feb 12. doi: 10.1111/bjd.16441.
    PubMed     Text format     Abstract available


  362. LONGO C, Lallas A, Kyrgidis A, Bassoli S, et al
    Wide skin markings pattern - melanoma descriptor or patient-related factor?: reply from authors.
    Br J Dermatol. 2018 Feb 7. doi: 10.1111/bjd.16430.
    PubMed     Text format     Abstract available


  363. RISHPON A, Marchetti M, Marghoob A
    Wide skin markings pattern - melanoma descriptor or patient-related factor?
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16420.
    PubMed     Text format     Abstract available


  364. VILLARREAL-MARTINEZ A, Bennassar A, Gonzalez S, Malvehy J, et al
    Application of in vivo reflectance confocal microscopy (RCM) and ex vivo fluorescence confocal microscopy (FCM) in most common subtypes of Basal Cell Carcinoma and correlation with histopathology.
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16421.
    PubMed     Text format     Abstract available


  365. LANGLEY RG, Papp K, Gooderham M, Zhang L, et al
    Efficacy and safety of continuous every 2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase 3 trial (IXORA-P).
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16426.
    PubMed     Text format     Abstract available


  366. FUJISAWA Y, Yoshino K, Otsuka A, Funakoshi T, et al
    Baseline neutrophil to lymphocyte ratio combined with serum LDH level associated with outcome of nivolumab immunotherapy in a Japanese advanced melanoma population.
    Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16427.
    PubMed     Text format     Abstract available


  367. TSAKOK T, Jabbar-Lopez ZK, Smith CH
    Subcutaneous methotrexate in patients with moderate to severe psoriasis: a critical appraisal.
    Br J Dermatol. 2018 Feb 5. doi: 10.1111/bjd.16424.
    PubMed     Text format     Abstract available


  368. ZHANG G, Chen H, Gao Y, Liu Y, et al
    Sirolimus for treatment of Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: A retrospective cohort study.
    Br J Dermatol. 2018 Feb 1. doi: 10.1111/bjd.16400.
    PubMed     Text format     Abstract available


  369. DANDO EE, Lim GFS, Ho J, James A, et al
    Image Gallery: Pigmented mammary Paget disease: a rare clinicopathological variant mimicking melanoma.
    Br J Dermatol. 2018;178:e143.
    PubMed     Text format    


  370. RAPHAEL AP, Soyer HP
    Automated diagnosis: shedding the light on skin cancer.
    Br J Dermatol. 2018;178:331-333.
    PubMed     Text format    


  371. CUST AE
    Prognostic features for acral lentiginous melanoma.
    Br J Dermatol. 2018;178:311-312.
    PubMed     Text format    


  372. RENCZ F
    Impact of dupilumab on health-related quality of life in patients with atopic dermatitis.
    Br J Dermatol. 2018;178:319-320.
    PubMed     Text format    


  373. BISSONNETTE R
    JAK inhibitors appear to have a bright future in the treatment of atopic dermatitis.
    Br J Dermatol. 2018;178:321.
    PubMed     Text format    


  374. MICALI G, Lacarrubba F
    Standardized classification tools in dermatology: time to focus on cutaneous warts.
    Br J Dermatol. 2018;178:330.
    PubMed     Text format    


  375. BELL KJL, Cust AE
    Beyond country-specific incidence and mortality: the global burden of melanoma.
    Br J Dermatol. 2018;178:315-316.
    PubMed     Text format    


  376. BALATO A, Raimondo A
    Novel interactions among ultraviolet B, skin and adipose tissue.
    Br J Dermatol. 2018;178:327-328.
    PubMed     Text format    


  377. SACH T
    Safety gains don't translate into reduced costs or increased QALYs for doxycycline compared with prednisolone for patients with bullous pemphigoid.
    Br J Dermatol. 2018;178:320-321.
    PubMed     Text format    


  378. VON SCHUCKMANN LA
    Is occupational sun exposure important for squamous cell carcinoma risk?
    Br J Dermatol. 2018;178:325-326.
    PubMed     Text format    


  379. STICHERLING M
    Ulcerative colitis: yet another paradoxical effect of tumour necrosis factor blockers?
    Br J Dermatol. 2018;178:333-334.
    PubMed     Text format    


  380. CARMICHAEL AJ, Harman KE
    Orf - a potential trigger for self-limiting epidermolysis bullosa acquisita-like blistering.
    Br J Dermatol. 2018;178:333.
    PubMed     Text format    


  381. HOLMES S
    Alopecia: the questions we need to answer.
    Br J Dermatol. 2018;178:330-331.
    PubMed     Text format    


  382. NAIK HB, Abuabara K
    Systematic reviews of case reports and case series: from anecdote to evidence.
    Br J Dermatol. 2018;178:317-318.
    PubMed     Text format    


  383. BAGATIN E
    Treating actinic keratosis: assessment of effectiveness, discomfort, costs and follow-up.
    Br J Dermatol. 2018;178:322-323.
    PubMed     Text format    


  384. VENDER R
    Survival of the fittest.
    Br J Dermatol. 2018;178:328-329.
    PubMed     Text format    


  385. SCHMITT-EGENOLF M
    What can we learn from 'dropouts' in clinical trials?
    Br J Dermatol. 2018;178:318-319.
    PubMed     Text format    


  386. KEEGEL T, Nixon RL
    Wet work and healthcare workers: use of hand disinfectants not associated with self-reported eczema.
    Br J Dermatol. 2018;178:324-325.
    PubMed     Text format    


  387. MCGRATH JA
    Concurrent hidradenitis suppurativa and Dowling-Degos disease taken down a 'Notch'.
    Br J Dermatol. 2018;178:328.
    PubMed     Text format    


  388. APFELBACHER C
    The time healthcare workers wear disposable gloves daily is associated with hand eczema in a dose-dependent fashion.
    Br J Dermatol. 2018;178:323-324.
    PubMed     Text format    


  389. HERTL M, Hashimoto T
    Response to 'Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis': reply from authors.
    Br J Dermatol. 2018;178:573-574.
    PubMed     Text format    


  390. JONKMAN MF, Meijer JM, Diercks GFH, Pas HH, et al
    Response to 'Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis'.
    Br J Dermatol. 2018;178:573.
    PubMed     Text format    


    January 2018
  391. WANG R, Dunlap RR, Darwish MA, Simpson EL, et al
    Initial validation of the Burden of Disease in Atopic Eczema instrument, a quality of life measure for adult atopic dermatitis.
    Br J Dermatol. 2018 Jan 30. doi: 10.1111/bjd.16398.
    PubMed     Text format     Abstract available


  392. KHOURY LR, Moller T, Zachariae C, Skov L, et al
    A prospective 52-week randomised controlled trial of patient-initiated care consultations for patients with psoriasis.
    Br J Dermatol. 2018 Jan 24. doi: 10.1111/bjd.16369.
    PubMed     Text format     Abstract available


  393. BORSARI S, Pampena R, Benati E, Bombonato C, et al
    In vivo dermoscopic and confocal microscopy multi-step algorithm to detect in situ melanomas.
    Br J Dermatol. 2018 Jan 21. doi: 10.1111/bjd.16364.
    PubMed     Text format     Abstract available


  394. STULL DE, Griffiths CEM, Gilloteau I, Zhao Y, et al
    Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis.
    Br J Dermatol. 2018 Jan 21. doi: 10.1111/bjd.16366.
    PubMed     Text format     Abstract available


  395. CHABY G, Valeyrie-Allanore L, Duong TA, Lebrun-Vignes B, et al
    Severe cutaneous adverse reactions due to inappropriate medication use.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16365.
    PubMed     Text format     Abstract available


  396. MARONAS-JIMENEZ L, Ortiz-Romero PL
    Aprepitant did not modify global disease activity in cutaneous T cell lymphomas.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16374.
    PubMed     Text format     Abstract available


  397. KWATRA SG, Boozalis E, Kwatra MM
    Effects of neuroimmune axis modulation by aprepitant on anti-pruritic and global disease severity in patients with cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16363.
    PubMed     Text format     Abstract available


  398. GRILL C, Laila B, Rubod A, Aktary Z, et al
    Epidermal melanocytes of segmental vitiligo show altered expression of E-cadherin, but not P-cadherin.
    Br J Dermatol. 2018 Jan 16. doi: 10.1111/bjd.16352.
    PubMed     Text format     Abstract available


  399. DIZON MP, Yu AM, Singh RK, Wan J, et al
    Systematic review of atopic dermatitis disease definition in studies using routinely-collected health data.
    Br J Dermatol. 2018 Jan 16. doi: 10.1111/bjd.16340.
    PubMed     Text format     Abstract available


  400. DE BRUIN-WELLER M, Graham NMH, Pirozzi G, Shumel B, et al
    Could conjunctivitis in dupilumab treated atopic dermatitis patients be caused by colonization with Demodex and increased IL-17 levels? Reply from authors.
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16348.
    PubMed     Text format     Abstract available


  401. BACHELEZ H
    Pustular psoriasis and related pustular skin diseases.
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16232.
    PubMed     Text format     Abstract available


  402. THYSSEN JP
    Could conjunctivitis in dupilumab treated atopic dermatitis patients be caused by colonization with demodex and increased IL-17 levels?
    Br J Dermatol. 2018 Jan 15. doi: 10.1111/bjd.16330.
    PubMed     Text format     Abstract available


  403. KOTB IS, Lewis BJ, Barker RN, Ormerod AD, et al
    Differential effects of phototherapy, adalimumab and betamethasone/calcipotriol on effector and regulatory T cells in psoriasis.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16336.
    PubMed     Text format     Abstract available


  404. YOSHIDA H, Nagaoka A, Komiya A, Aoki M, et al
    Reduction of hyaluronan and increased expression of HYBID (KIAA1199) correlate with clinical symptoms in photoaged skin.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16335.
    PubMed     Text format     Abstract available


  405. SEO HM, Moon GT, Song YM, Gee HY, et al
    Expression of YAP and TAZ in molluscum contagiosum virus infected skin.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16333.
    PubMed     Text format     Abstract available


  406. GRIFFITHS CEM, Jo SJ, Naldi L, Romiti R, et al
    A multidimensional assessment of the burden of psoriasis: Results from a multinational dermatologist and patient survey.
    Br J Dermatol. 2018 Jan 12. doi: 10.1111/bjd.16332.
    PubMed     Text format     Abstract available


  407. RANDA H, Lomholt JJ, Skov L, Zachariae R, et al
    Health-Related Quality of Life in adolescents with psoriasis: an interview-based study.
    Br J Dermatol. 2018 Jan 8. doi: 10.1111/bjd.16326.
    PubMed     Text format     Abstract available


  408. BEECKMAN D, Van den Bussche K, Alves P, Arnold Long MC, et al
    Towards an international language for Incontinence-Associated Dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorisation Tool (GLOBIAD) in 30 countries.
    Br J Dermatol. 2018 Jan 8. doi: 10.1111/bjd.16327.
    PubMed     Text format     Abstract available


  409. LAINO AM, Berry EG, Jagirdar K, Lee KJ, et al
    Iris pigmented lesions as a marker of cutaneous melanoma risk: an Australian case-control study.
    Br J Dermatol. 2018 Jan 8. doi: 10.1111/bjd.16323.
    PubMed     Text format     Abstract available


  410. THOMSON J, Wernham AGH, Williams HC
    Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal.
    Br J Dermatol. 2018 Jan 6. doi: 10.1111/bjd.16317.
    PubMed     Text format     Abstract available


  411. LEWIS FM, Tatnall FM, Velangi SS, Bunker CB, et al
    British Association of Dermatologists guidelines for the management of lichen sclerosus 2018.
    Br J Dermatol. 2018 Jan 4. doi: 10.1111/bjd.16241.
    PubMed     Text format     Abstract available


  412. TSCHANDL P, Wiesner T
    Advances in the diagnosis of pigmented skin lesions.
    Br J Dermatol. 2018;178:9-11.
    PubMed     Text format    


  413. VERYKIOU S, Edwards N, Hill D
    How breakthroughs in translational research have impacted treatment strategies for melanoma.
    Br J Dermatol. 2018;178:5-8.
    PubMed     Text format    


  414. CHASSET F, Haroche J
    Cutaneous manifestations of paediatric Erdheim-Chester disease, a histiocytosis of the 'L' group.
    Br J Dermatol. 2018;178:31-32.
    PubMed     Text format    


  415. PRINSEN CAC
    T-QoL: a quality of life outcome measure specifically developed for adolescents with skin diseases.
    Br J Dermatol. 2018;178:23-25.
    PubMed     Text format    


  416. SANCLEMENTE G
    What can we learn from psoriasis pharmacogenomics research?
    Br J Dermatol. 2018;178:17.
    PubMed     Text format    


  417. MILLINGTON GWM, Collins A, Lovell CR, Leslie TA, et al
    British Association of Dermatologists' guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018.
    Br J Dermatol. 2018;178:34-60.
    PubMed     Text format    


  418. MUTHIAH S, Tang D, Nasr B, Verykiou S, et al
    A new era in holistic care: bridging the gap between dermatologists and oncologists for the treatment of malignant melanoma.
    Br J Dermatol. 2018;178:1-4.
    PubMed     Text format    


  419. RENCZ F
    Patients with psoriasis on a new trajectory: long-term improvement in quality of life with biologics.
    Br J Dermatol. 2018;178:29-30.
    PubMed     Text format    


  420. WIESNER T, Zbyszewski A
    Progress in the diagnosis and therapy of melanoma.
    Br J Dermatol. 2018;178:12-14.
    PubMed     Text format    


  421. NALDI L
    Biologic treatment for psoriasis and cancer: an increased risk for most cancers could not be ruled out.
    Br J Dermatol. 2018;178:19.
    PubMed     Text format    


  422. SILLING S, Akgul B
    Treatment success in cutaneous warts: morphology and human papillomavirus type matter.
    Br J Dermatol. 2018;178:30-31.
    PubMed     Text format    


  423. SEKHON S, Koo J
    Indirubin: a novel topical agent in the treatment of psoriasis.
    Br J Dermatol. 2018;178:21.
    PubMed     Text format    


  424. WEHNER MR
    Sunscreen and melanoma prevention: evidence and expectations.
    Br J Dermatol. 2018;178:15-16.
    PubMed     Text format    


  425. COHEN AD, Zisman D
    Growing evidence for coronary artery disease risk factors in patients with severe hidradenitis suppurativa.
    Br J Dermatol. 2018;178:27-28.
    PubMed     Text format    


  426. FELDMAN SR
    Yet another step forward!
    Br J Dermatol. 2018;178:22.
    PubMed     Text format    


  427. EZZEDINE K, Eleftheriadou V
    Vitiligo and quality of life: the dark face of whiteness.
    Br J Dermatol. 2018;178:28-29.
    PubMed     Text format    


  428. HWANG SJE, Fernandez-Penas P
    Pigmentary evolution with pembrolizumab use.
    Br J Dermatol. 2018;178:32-33.
    PubMed     Text format    


  429. ALBRECHT J, Gerdes S
    When to switch biologics: some answers, but lots of questions too.
    Br J Dermatol. 2018;178:20.
    PubMed     Text format    


  430. TEASDALE E
    The benefit of nested qualitative studies in dermatology randomized controlled trials.
    Br J Dermatol. 2018;178:25-26.
    PubMed     Text format    


  431. DRUCKER AM, Doiron PR
    Understanding common but understudied diseases in dermatology.
    Br J Dermatol. 2018;178:22-23.
    PubMed     Text format    


  432. GAMBICHLER T, Wolf P
    Irradiance, as well as body site and timing of readings, is important in determining ultraviolet A minimal erythemal dose: reply from the authors.
    Br J Dermatol. 2018;178:298-299.
    PubMed     Text format    


  433. ALBRECHT J, Mehta S, Bigby M
    Development of resistance to Mycobacterium tuberculosis is manageable in hidradenitis suppurativa. Response to 'Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?'
    Br J Dermatol. 2018;178:300.
    PubMed     Text format    


  434. EADIE E, Ibbotson SH, Dawe RS
    Irradiance, as well as body site and timing of readings, is important in determining ultraviolet A minimal erythema dose.
    Br J Dermatol. 2018;178:297-298.
    PubMed     Text format    


  435. DAVILA-SEIJO P, Descalzo MA
    Registries as real-world cohort studies that are useful and necessary in the pyramid of evidence.
    Br J Dermatol. 2018;178:300-301.
    PubMed     Text format    


    December 2017
  436. MCINERNEY-LEO AM, Wheeler L, Sturm RA, Tan JM, et al
    Point mutation in p14(ARF) -specific exon 1beta of CDKN2A causing familial melanoma and astrocytoma.
    Br J Dermatol. 2017 Dec 26. doi: 10.1111/bjd.16275.
    PubMed     Text format     Abstract available


  437. DE UNAMUNO BUSTOS B, Murria Estal R, Perez Simo G, Simarro Farinos J, et al
    Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
    Br J Dermatol. 2017 Dec 26. doi: 10.1111/bjd.16254.
    PubMed     Text format     Abstract available


  438. AAREBROT AK, Solberg SM, Davies R, Bader LI, et al
    Phosphorylation of intracellular signaling molecules in peripheral blood cells from psoriasis patients on originator or biosimilar infliximab.
    Br J Dermatol. 2017 Dec 23. doi: 10.1111/bjd.16269.
    PubMed     Text format     Abstract available


  439. KRASUSKA M, Lavda AC, Thompson AR, Millings A, et al
    The role of adult attachment orientation and coping in psychological adjustment to living with skin conditions.
    Br J Dermatol. 2017 Dec 23. doi: 10.1111/bjd.16268.
    PubMed     Text format     Abstract available


  440. SALOMON G, Maza A, Boulinguez S, Paul C, et al
    Efficacy of anti-PD-1 on skin carcinomas and melanoma metastases in an Xeroderma Pigmentosum patient.
    Br J Dermatol. 2017 Dec 23. doi: 10.1111/bjd.16270.
    PubMed     Text format     Abstract available


  441. GOLBARI NM, Lockwood SJ, Porter ML, Kimball AB, et al
    Reply to: "An exploratory study using framework analysis to investigate health-seeking behaviour in patients with psoriasis".
    Br J Dermatol. 2017 Dec 22. doi: 10.1111/bjd.16266.
    PubMed     Text format     Abstract available


  442. GHETTI M, Topouzi H, Theocharidis G, Papa V, et al
    Sub-Populations of Dermal Skin Fibroblasts Secrete Distinct Extracellular Matrix: Implications for Using Skin Substitutes in the Clinic.
    Br J Dermatol. 2017 Dec 20. doi: 10.1111/bjd.16255.
    PubMed     Text format     Abstract available


  443. TSAI TF, Weng HJ, Wang TS
    Clinical experience of secukinumab in the treatment of erythrodermic psoriasis: a case series.
    Br J Dermatol. 2017 Dec 19. doi: 10.1111/bjd.16252.
    PubMed     Text format     Abstract available


  444. SVENSSON A, Ofenloch RF, Bruze M, Naldi L, et al
    Prevalence of skin disease in a population based sample of adults out of five European countries.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16248.
    PubMed     Text format     Abstract available


  445. KLIJN SL, van den Reek JMPA, van de Wetering G, van der Kolk A, et al
    Biologic treatment sequences for plaque psoriasis: a cost-utility analysis based on 10 years of Dutch real-world evidence from BioCAPTURE.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16247.
    PubMed     Text format     Abstract available


  446. DE WIT J, Totte JEE, van Buchem FJM, Pasmans SGMA, et al
    The prevalence of antibody responses against Staphylococcus aureus antigens in patients with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16251.
    PubMed     Text format     Abstract available


  447. KAMSTRUP MR, Skov L, Zachariae C, Thyssen JP, et al
    Psoriasis and risk of malignant lymphoma: A population-based cohort study.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16245.
    PubMed     Text format     Abstract available


  448. OLSEN CM, Wilson LF, Green AC, Biswas N, et al
    How many melanomas might be prevented if more people applied sunscreen regularly?
    Br J Dermatol. 2017 Dec 14. doi: 10.1111/bjd.16079.
    PubMed     Text format     Abstract available


  449. GERBENS LAA, Hamann SAS, Brouwer MWD, Roekevisch E, et al
    Methotrexate and azathioprine in severe atopic dermatitis: a 5-year follow up study of a randomised controlled trial.
    Br J Dermatol. 2017 Dec 13. doi: 10.1111/bjd.16240.
    PubMed     Text format     Abstract available


  450. PRUSSICK RB, Miele L
    Nonalcoholic fatty liver disease in patients with psoriasis: A consequence of systemic inflammatory burden?
    Br J Dermatol. 2017 Dec 13. doi: 10.1111/bjd.16239.
    PubMed     Text format     Abstract available


  451. NEMOTO O, Hirose K, Shibata S, Li K, et al
    Safety and Efficacy of guselkumab in Japanese patients with moderate-to-severe plaque psoriasis: A Randomised, Placebo-Controlled, Ascending Dose Study.
    Br J Dermatol. 2017 Dec 9. doi: 10.1111/bjd.16236.
    PubMed     Text format     Abstract available


  452. THYSSEN JP, Halling-Overgaard AS, Andersen YMF, Gislason G, et al
    The association between cardiovascular disease and type 2 diabetes in adults with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Dec 6. doi: 10.1111/bjd.16215.
    PubMed     Text format     Abstract available


  453. AHMED A, Solman L, Williams HC
    Magnitude of benefit for topical crisaborole in the treatment of atopic dermatitis in children and adults does not look promising: a critical appraisal.
    Br J Dermatol. 2017 Dec 3. doi: 10.1111/bjd.16046.
    PubMed     Text format     Abstract available


  454. EATON LH, Mellody KT, Pilkington SM, Dearman RJ, et al
    Impaired Langerhans' cell migration in psoriasis is due to an altered keratinocyte phenotype induced by interleukin-17.
    Br J Dermatol. 2017 Dec 1. doi: 10.1111/bjd.16172.
    PubMed     Text format     Abstract available


  455. GONZALEZ-QUESADA A, Bastida J, Rivero-Vera JC, Piris-Pinilla MA, et al
    Image Gallery: Metachronic occurrence of primary cutaneous marginal zone B-cell lymphoma and primary cutaneous Rosai-Dorfman disease in the same patient.
    Br J Dermatol. 2017;177:e355.
    PubMed     Text format    


  456. TOLLEFSON M, Siegel D
    Advancing paediatric psoriasis treatment options for children.
    Br J Dermatol. 2017;177:1470-1471.
    PubMed     Text format    


  457. SCARISBRICK JJ
    Brentuximab vedotin is an effective therapy for CD30(+) mycosis fungoides and cutaneous anaplastic large-cell lymphoma: what is the cost?
    Br J Dermatol. 2017;177:1474-1475.
    PubMed     Text format    


  458. LAIMER M
    MAPK14 as candidate for genetic susceptibility to diabetic foot ulcer.
    Br J Dermatol. 2017;177:1482-1483.
    PubMed     Text format    


  459. LUO Y, Liu J
    Image Gallery: Primary cutaneous precursor B-lymphoblastic lymphoma in an infant.
    Br J Dermatol. 2017;177:e353.
    PubMed     Text format    


  460. KIRBY B
    Worldwide perspective of biosimilars for psoriasis.
    Br J Dermatol. 2017;177:1473.
    PubMed     Text format    


  461. VILLANI R, Khosrotehrani K
    Oncogenes and morphogens: intricacies of targeted therapy in cutaneous basal cell carcinoma.
    Br J Dermatol. 2017;177:1472-1473.
    PubMed     Text format    


  462. GALLUCCI RM
    Transforming growth factor-beta and psoriasis: a new link.
    Br J Dermatol. 2017;177:1480-1481.
    PubMed     Text format    


    November 2017
  463. TOTTE JEE, Pardo LM, Fieten KB, de Wit J, et al
    The IgG response against Staphylococcus aureus is associated with severe atopic dermatitis in children.
    Br J Dermatol. 2017 Nov 30. doi: 10.1111/bjd.16153.
    PubMed     Text format     Abstract available


  464. PALLER AS
    Clarification of methodology and further results from the pivotal phase 3 study of crisaborole for mild-moderate atopic dermatitis.
    Br J Dermatol. 2017 Nov 30. doi: 10.1111/bjd.16047.
    PubMed     Text format    


  465. DE BRUIN-WELLER M, Thaci D, Smith CH, Reich K, et al
    Dupilumab with concomitant topical corticosteroids in adult patients with atopic dermatitis who are not adequately controlled with or are intolerant to ciclosporin A, or when this treatment is medically inadvisable: a placebo-controlled, randomized ph
    Br J Dermatol. 2017 Nov 28. doi: 10.1111/bjd.16156.
    PubMed     Text format     Abstract available


  466. CHAN SA, Wernham AGH, Stembridge N, Harper N, et al
    Do perioperative antibiotics reduce the risk of surgical site infections following excision of ulcerated skin cancers? a critically appraised topic.
    Br J Dermatol. 2017 Nov 28. doi: 10.1111/bjd.16157.
    PubMed     Text format     Abstract available


  467. HOLMES J, von Braunmuhl T, Berking C, Sattler E, et al
    Optical coherence tomography of basal cell carcinoma: influence of location, subtype, observer variability and image quality on diagnostic performance.
    Br J Dermatol. 2017 Nov 28. doi: 10.1111/bjd.16154.
    PubMed     Text format     Abstract available


  468. CHENG L, Sun B, Xiong Y, Hu L, et al
    The minor allele HCP5 rs3099844 A, PSORS1C1 rs3131003 G are associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese: a multicentre retrospective case-control clinical study.
    Br J Dermatol. 2017 Nov 28. doi: 10.1111/bjd.16151.
    PubMed     Text format     Abstract available


  469. RUFF SMD, Engebretsen KA, Zachariae C, Johansen JD, et al
    The association between atopic dermatitis and hand eczema: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Nov 24. doi: 10.1111/bjd.16147.
    PubMed     Text format     Abstract available


  470. WARREN RB, Brnabic A, Saure D, Langley RG, et al
    Matching-Adjusted Indirect Comparison of Efficacy in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab Versus Secukinumab.
    Br J Dermatol. 2017 Nov 24. doi: 10.1111/bjd.16140.
    PubMed     Text format     Abstract available


  471. DING S, Chen J, Zeng Q, Lu J, et al
    Chronic sun exposure is associated with distinct histone acetylation changes in human skin.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16129.
    PubMed     Text format     Abstract available


  472. KANG EG, Wu S, Gupta A, von Mackensen YL, et al
    A Phase I Randomised Controlled Trial to Evaluate Safety and Clinical Effect of Topically Applied GSK2981278 Ointment in a Psoriasis Plaque Test.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16131.
    PubMed     Text format     Abstract available


  473. VASSEUR P, Pohin M, Jegou JF, Favot L, et al
    Liver fibrosis is associated with cutaneous inflammation in the imiquimod-induced murine model of psoriasiform dermatitis.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16137.
    PubMed     Text format     Abstract available


  474. MARONAS-JIMENEZ L, Estrach T, Gallardo F, Perez A, et al
    Aprepitant improves refractory pruritus in primary cutaneous T-cell lymphomas: experience of the Spanish Working Group on Cutaneous Lymphomas.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16128.
    PubMed     Text format     Abstract available


  475. WINSLOW UC, Nordestgaard BG, Afzal S
    High plasma 25-hydroxyvitamin D and high risk of non-melanoma skin cancer: a Mendelian randomisation study of 97849 individuals.
    Br J Dermatol. 2017 Nov 16. doi: 10.1111/bjd.16127.
    PubMed     Text format     Abstract available


  476. STOFFEL E, Maier H, Riedl E, Bruggen MC, et al
    Analysis of anti-TNF-induced skin lesions reveals strong Th1 activation with some distinct immunological characteristics.
    Br J Dermatol. 2017 Nov 16. doi: 10.1111/bjd.16126.
    PubMed     Text format     Abstract available


  477. SNAST I, Reiter O, Atzmony L, Leshem YA, et al
    Psychological stress and psoriasis. A systematic review and meta-analysis.
    Br J Dermatol. 2017 Nov 9. doi: 10.1111/bjd.16116.
    PubMed     Text format     Abstract available


  478. TZANEVA S, Geroldinger A, Trattner H, Tanew A, et al
    Fumaric acid esters in combination with a 6-week course of narrow-band UVB provides for an accelerated response as compared to fumaric acid esters monotherapy in patients with moderate to severe plaque psoriasis: A randomized prospective clinical stud
    Br J Dermatol. 2017 Nov 8. doi: 10.1111/bjd.16106.
    PubMed     Text format     Abstract available


  479. BURDEN-TEH E, Phillips RC, Thomas KS, Ratib S, et al
    A systematic review of diagnostic criteria for psoriasis in adults and children: Evidence from studies with a primary aim to develop or validate diagnostic criteria.
    Br J Dermatol. 2017 Nov 6. doi: 10.1111/bjd.16104.
    PubMed     Text format     Abstract available


  480. DEL PUERTO C, Navarrete-Dechent C, Molgo M, Camargo CA Jr, et al
    Immunohistochemical expression of vitamin D receptor in melanocytic nevi and cutaneous melanoma. A case-control study.
    Br J Dermatol. 2017 Nov 6. doi: 10.1111/bjd.16103.
    PubMed     Text format     Abstract available


  481. EGEBERG A, Ottosen MB, Gniadecki R, Broesby-Olsen S, et al
    Safety, efficacy, and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis.
    Br J Dermatol. 2017 Nov 1. doi: 10.1111/bjd.16102.
    PubMed     Text format     Abstract available


  482. FINLAY AY
    Real-world effect of biologics on quality of life in psoriasis.
    Br J Dermatol. 2017;177:1164-1165.
    PubMed     Text format    


  483. ROH MR
    Role of endothelial dysfunction in pathological cutaneous scarring.
    Br J Dermatol. 2017;177:1153.
    PubMed     Text format    


  484. FLORENCE L, Fuller LC
    Washing with water and glycerine improves skin barrier function and quality of life in patients with podoconiosis.
    Br J Dermatol. 2017;177:1166.
    PubMed     Text format    


  485. LUO Y, Liu J
    Image Gallery: Moth-eaten alopecia as the only cutaneous symptom of acquired secondary syphilis in a 2-year-old boy.
    Br J Dermatol. 2017;177:e227.
    PubMed     Text format    


  486. DANBY SG
    Staphylococcus aureus in atopic dermatitis: a diverse problem?
    Br J Dermatol. 2017;177:1164.
    PubMed     Text format    


  487. DRUCKER AM
    Making sense of measures of clinical signs for atopic dermatitis.
    Br J Dermatol. 2017;177:1158-1159.
    PubMed     Text format    


  488. SILVERBERG JI
    Are moisturizers effective in the treatment of atopic dermatitis?
    Br J Dermatol. 2017;177:1154.
    PubMed     Text format    


  489. HARWOOD CA, Arron ST, Proby CM, Asgari MM, et al
    Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma.
    Br J Dermatol. 2017;177:1150-1151.
    PubMed     Text format    


  490. RAZMI T M, De D, Handa S, Saikia UN, et al
    Image Gallery: Generalized circinate cutaneous lesions simulating circinate balanitis.
    Br J Dermatol. 2017;177:e224.
    PubMed     Text format    


  491. HAMMER K, Hugel R, Lange-Asschenfeldt B, Painsi C, et al
    Image Gallery: Cutaneous signs of acute pancreatitis.
    Br J Dermatol. 2017;177:e222.
    PubMed     Text format    


    October 2017
  492. GRANDO SA, Zachary CB
    THE NON-NEURONAL AND NON-MUSCULAR EFFECTS OF BOTULINUM TOXIN: A Graceful Opportunity for a Deadly Molecule to Treat a Human Disease in the Skin and Beyond.
    Br J Dermatol. 2017 Oct 31. doi: 10.1111/bjd.16080.
    PubMed     Text format     Abstract available


  493. HARWOOD CA, Toland AE, Proby CM, Euvrard S, et al
    The pathogenesis of cutaneous squamous cell carcinoma in organ transplant recipients.
    Br J Dermatol. 2017 Oct 30. doi: 10.1111/bjd.15956.
    PubMed     Text format     Abstract available


  494. BLOMBERG M, He SY, Harwood C, Arron ST, et al
    Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients.
    Br J Dermatol. 2017 Oct 30. doi: 10.1111/bjd.15950.
    PubMed     Text format     Abstract available


  495. DIXON LJ, Witcraft SM, McCowan NK, Brodell RT, et al
    Stress and Skin Disease Quality of Life: The Moderating Role of Anxiety Sensitivity Social Concerns.
    Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16082.
    PubMed     Text format     Abstract available


  496. CORDEL N, Hebert V, Vega Rua A, Herrmann-Storck C, et al
    In vivo Zika virus detection in human skin.
    Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16096.
    PubMed     Text format     Abstract available


  497. STAIMAN A, Hsu DY, Silverberg JI
    Epidemiology of Staphylococcal Scalded Skin Syndrome in United States Children.
    Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16097.
    PubMed     Text format     Abstract available


  498. EGGEN CAM, Lommerts JE, van Zuuren EJ, Limpens J, et al
    Laser treatment of congenital melanocytic nevi: a systematic review.
    Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16094.
    PubMed     Text format     Abstract available


  499. TRAN AD, Fogarty G, Nowak AK, Espinoza D, et al
    A systematic review and meta-analysis of utility estimates in melanoma.
    Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16098.
    PubMed     Text format     Abstract available


  500. CHEN L, Tsai TF
    HLA-Cw6 and psoriasis.
    Br J Dermatol. 2017 Oct 26. doi: 10.1111/bjd.16083.
    PubMed     Text format     Abstract available


  501. LANGAN EA, Griffiths CEM, Solbach W, Knobloch JK, et al
    The role of the microbiome in psoriasis: moving from disease description to treatment prediction?
    Br J Dermatol. 2017 Oct 26. doi: 10.1111/bjd.16081.
    PubMed     Text format     Abstract available


  502. VAKHARIA PP, Chopra R, Sacotte R, Patel N, et al
    Severity strata for five patient-reported outcomes in adults with atopic dermatitis.
    Br J Dermatol. 2017 Oct 19. doi: 10.1111/bjd.16078.
    PubMed     Text format     Abstract available


  503. SEO JW, Ha SM, Song KH
    Insulin-Like Growth Factor-II mRNA-Binding Protein 3 as a Novel Prognostic Biomarker for Acral Lentiginous Melanoma.
    Br J Dermatol. 2017 Oct 19. doi: 10.1111/bjd.16077.
    PubMed     Text format     Abstract available


  504. GELLER S, Myskowski PL, Kim YH, Moskowitz A, et al
    The optimal regimen of brentuximab vedotin for CD30+ cutaneous lymphoma: Are we there yet?
    Br J Dermatol. 2017 Oct 10. doi: 10.1111/bjd.16052.
    PubMed     Text format     Abstract available


  505. STROBER BE, Langley RGB, Menter A, Magid M, et al
    No Elevated Risk for Depression, Anxiety, or Suicidality with Secukinumab in a Pooled Analysis of Data from 10 Clinical Studies in Moderate-to-Severe Plaque Psoriasis.
    Br J Dermatol. 2017 Oct 9. doi: 10.1111/bjd.16051.
    PubMed     Text format     Abstract available


  506. PAPP KA, Leonardi CL, Blauvelt A, Reich K, et al
    Ixekizumab treatment for psoriasis: Integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER-1, UNCOVER-2, UNCOVER-3).
    Br J Dermatol. 2017 Oct 9. doi: 10.1111/bjd.16050.
    PubMed     Text format     Abstract available


  507. RUNGAPIROMNAN W, Yiu ZZN, Warren RB, Griffiths CEM, et al
    Reply to 'Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials': reply from the authors.
    Br J Dermatol. 2017 Oct 9. doi: 10.1111/bjd.16043.
    PubMed     Text format     Abstract available


  508. BASSOLI S, Kyrgidis A, Ciardo S, Casari A, et al
    Uncovering the diagnostic dermoscopic features of flat melanomas located on the lower limbs.
    Br J Dermatol. 2017 Oct 7. doi: 10.1111/bjd.16030.
    PubMed     Text format     Abstract available


  509. VALLERAND IA, Patten SB
    Systemic retinoids and psychiatric disorders in patients with skin diseases: a multifactorial relationship.
    Br J Dermatol. 2017 Oct 3. doi: 10.1111/bjd.16018.
    PubMed     Text format     Abstract available


  510. NGUYEN MO, Nguyen HT, Asgari MM
    Towards the use of precision medicine in predicting cutaneous squamous cell carcinoma risk among solid organ transplant recipients.
    Br J Dermatol. 2017;177:901-902.
    PubMed     Text format    


  511. EGEBERG A
    Cardiometabolic disease in atopic dermatitis: the heart of the matter.
    Br J Dermatol. 2017;177:898-899.
    PubMed     Text format    


  512. SCHAIDER H, Sturm RA
    The evolving universe of BRAF mutations in melanoma.
    Br J Dermatol. 2017;177:893.
    PubMed     Text format    


  513. EGEBERG A
    Getting tired of psoriasis?
    Br J Dermatol. 2017;177:899-900.
    PubMed     Text format    


  514. HOFMANN H
    A foot tumour as late cutaneous Lyme borreliosis: a new entity or a variant of an inflammatory proliferative reaction to Borrelia burgdorferi?
    Br J Dermatol. 2017;177:906-907.
    PubMed     Text format    


  515. HAY R
    Staphylococcus aureus and psoriasis: time for a re-appraisal?
    Br J Dermatol. 2017;177:894-895.
    PubMed     Text format    


  516. ROBINSON JK, Spring B
    Personalized melanoma genomic risk information:perception of shared risk initiates sharing with family.
    Br J Dermatol. 2017;177:890-891.
    PubMed     Text format    


  517. ZYCHOWSKA M, Maj J
    Image Gallery: Cutaneous metastases from hidden carcinoma of the penis.
    Br J Dermatol. 2017;177:e161.
    PubMed     Text format    


  518. SODERLUND-VENERMO M
    Clinical significance of parvovirus B19 DNA in cutaneous biopsies.
    Br J Dermatol. 2017;177:900-901.
    PubMed     Text format    


  519. BALAK DMW
    First-line systemic treatment of psoriasis: staying conventional or going biologic?
    Br J Dermatol. 2017;177:897-898.
    PubMed     Text format    


  520. CHU L, Zhang M, Ran Y
    Further progress for therapeutic solutions in psoriasis.
    Br J Dermatol. 2017;177:896-897.
    PubMed     Text format    


  521. SEMINARA NM, Pomeranz MK
    Unravelling the links between malignancy, cytokines and neutrophilic eruptions.
    Br J Dermatol. 2017;177:905-906.
    PubMed     Text format    


  522. ASERO R
    Towards a better categorization of patients with chronic urticaria.
    Br J Dermatol. 2017;177:903-904.
    PubMed     Text format    


  523. TAN J
    Acne guidelines: pearls, pitfalls and questions.
    Br J Dermatol. 2017;177:892-893.
    PubMed     Text format    


  524. YUAN H, Pan M
    Endoscopic characteristics of oesophagus involvement in mucous membrane pemphigoid.
    Br J Dermatol. 2017;177:902-903.
    PubMed     Text format    


  525. BETZ RC
    A path through the reticulate pigmentation disorder jungle.
    Br J Dermatol. 2017;177:893-894.
    PubMed     Text format    


  526. VOSSEN ARJV, van der Zee HH, Prens EP
    Sequence variants in hidradenitis suppurativa: in search of the pathogenic mechanisms.
    Br J Dermatol. 2017;177:895-896.
    PubMed     Text format    


    September 2017
  527. NAKAGAWA H, Nemoto O, Igarashi A, Nagata T, et al
    Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: A phase 2, multi-centre, randomised, vehicle-controlled clinical study.
    Br J Dermatol. 2017 Sep 28. doi: 10.1111/bjd.16014.
    PubMed     Text format     Abstract available


  528. SCHMIEDER GJ, Draelos ZD, Pariser DM, Banfield C, et al
    Efficacy and safety of the Janus Kinase 1 inhibitor PF-04965842 in patients with moderate to severe psoriasis: phase 2, randomized, double-blind, placebo-controlled study.
    Br J Dermatol. 2017 Sep 26. doi: 10.1111/bjd.16004.
    PubMed     Text format     Abstract available


  529. HOGENDOORN GK, Bruggink SC, Hermans KE, Kouwenhoven STP, et al
    Developing and validating the CWARTS diagnostic tool, a novel clinical assessment and classification system for cutaneous warts.
    Br J Dermatol. 2017 Sep 26. doi: 10.1111/bjd.15999.
    PubMed     Text format     Abstract available


  530. NOREN P, Hagstromer L, Alimohammadi M, Melin L, et al
    The positive effects of habit reversal treatment of scratching in children with atopic dermatitis: A randomised controlled study.
    Br J Dermatol. 2017 Sep 23. doi: 10.1111/bjd.16009.
    PubMed     Text format     Abstract available


  531. GORDON KB, Blauvelt A, Foley P, Song M, et al
    Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: A pooled analysis of the Phase 3 VOYAGE 1 and VOYAGE 2 studies.
    Br J Dermatol. 2017 Sep 22. doi: 10.1111/bjd.16008.
    PubMed     Text format     Abstract available


  532. MAGLIE R, Di Cesare A, Lazzeri L, Pescitelli L, et al
    Lichen Planus triggered by infliximab biosimilar CT-P13 and recurred during secukinumab treatment.
    Br J Dermatol. 2017 Sep 22. doi: 10.1111/bjd.16003.
    PubMed     Text format     Abstract available


  533. MACARTHUR KM, Cohen BA
    Tailoring Diagnostic Studies in Hand, Foot, and Mouth Disease: Utility of PCR testing of Lesional Skin.
    Br J Dermatol. 2017 Sep 21. doi: 10.1111/bjd.15991.
    PubMed     Text format     Abstract available


  534. SIGURGEIRSSON B, Luger T
    A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - author response.
    Br J Dermatol. 2017 Sep 21. doi: 10.1111/bjd.15849.
    PubMed     Text format    


  535. NAGTZAAM IF, Peeters VPM, Vreeburg M, Wagner A, et al
    Novel CLDN1 mutation in ichthyosis-hypotrichosis-sclerosing-cholangitis syndrome without signs of liver disease.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15996.
    PubMed     Text format     Abstract available


  536. HIETIKKO M, Hervonen K, Salmi T, Ilus T, et al
    Disappearance of epidermal transglutaminase and IgA deposits from the papillary dermis of dermatitis herpetiformis patients after a long-term gluten-free diet.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15995.
    PubMed     Text format     Abstract available


  537. HOTZ A, Fagerberg C, Vahlquist A, Bygum A, et al
    Identification of Mutations in SDR9C7 in 6 Families with Autosomal Recessive Congenital Ichthyosis.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15994.
    PubMed     Text format     Abstract available


  538. MAJEED-ARISS R, McPhee M, Bundy C, Griffiths CEM, et al
    Developing a protocol to identify and prioritise research questions for psoriasis: A James Lind Alliance Priority Setting Partnership.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15992.
    PubMed     Text format     Abstract available


  539. CHEE SN, Novakovic L, Fassihi H, Garibaldinos T, et al
    Chronic actinic dermatitis: successful treatment with PUVA photochemotherapy.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15969.
    PubMed     Text format     Abstract available


  540. STRANZENBACH R, Dippel E, Schlaak M, Stadler R, et al
    Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma: reply from authors.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15972.
    PubMed     Text format     Abstract available


  541. LEWIS DJ, Kim YH, Duvic M
    Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15970.
    PubMed     Text format     Abstract available


  542. EGEBERG A, Nast A
    The value and pitfalls of biologics registries for psoriasis.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15971.
    PubMed     Text format     Abstract available


  543. CORK MJ, Danby SG
    The British Skin Foundation: 20 years of supporting dermatology research.
    Br J Dermatol. 2017;177:608-609.
    PubMed     Text format    


  544. QU H, Zhao Z, Yu J
    Image Gallery: Cutaneous presentation of disseminated cryptococcosis in a patient with undiagnosed HIV infection.
    Br J Dermatol. 2017;177:e73.
    PubMed     Text format    


  545. PRINSEN CAC
    Changing patients' understanding of psoriasis is promising.
    Br J Dermatol. 2017;177:616-617.
    PubMed     Text format    


  546. ROTA M
    Evidence for an association between alcohol intake and an increased risk of nonmelanoma skin cancer.
    Br J Dermatol. 2017;177:611-612.
    PubMed     Text format    


  547. ZNAOR A
    Melanoma burden, healthcare utilization and the potential for overdiagnosis in the elderly U.S. population.
    Br J Dermatol. 2017;177:625.
    PubMed     Text format    


  548. GISONDI P
    High prevalence of alcohol use disorders in patients with inflammatory skin diseases applies to both psoriasis and eczema.
    Br J Dermatol. 2017;177:606-607.
    PubMed     Text format    


  549. COWDELL F
    Health-seeking behaviour in people with psoriasis.
    Br J Dermatol. 2017;177:615-616.
    PubMed     Text format    


  550. DOBREV H
    Organization of the dermal matrix impacts the biomechanical properties of skin.
    Br J Dermatol. 2017;177:622-623.
    PubMed     Text format    


  551. PUIG L
    Choice of first-line biologic therapy in psoriasis: understanding the past and shaping the future?
    Br J Dermatol. 2017;177:623-624.
    PubMed     Text format    


  552. QU H, Song Y, Li R, Yu J, et al
    Image Gallery: An unusual cutaneous presentation of disseminated penicilliosis marneffei in an immunocompetent patient.
    Br J Dermatol. 2017;177:e67.
    PubMed     Text format    


  553. HABER R, Bourrat E, Derache AF, Rivet J, et al
    Image Gallery: Juvenile cutaneous chronic graft-versus-host disease presenting as bullous pemphigoid.
    Br J Dermatol. 2017;177:e69.
    PubMed     Text format    


  554. EMTESTAM L, Sartorius K
    Glucagon-like peptide-1 agonists for treatment of hidradenitis suppurativa.
    Br J Dermatol. 2017;177:625-627.
    PubMed     Text format    


  555. SHARMA VK, Bhatia R
    Vitiligo and the psyche.
    Br J Dermatol. 2017;177:612-613.
    PubMed     Text format    


  556. PRIOR J
    Qualitative study of online discussion forums about acne.
    Br J Dermatol. 2017;177:616.
    PubMed     Text format    


  557. ARENTS BWM
    Eczema treatment: it takes time to do no harm.
    Br J Dermatol. 2017;177:613-614.
    PubMed     Text format    


  558. RAO S, Arbiser JL
    Promoting intolerance: learning from warts.
    Br J Dermatol. 2017;177:621-622.
    PubMed     Text format    


  559. TENSEN CP, Vermeer MH
    MicroRNA-155 potentiates tumour development in mycosis fungoides.
    Br J Dermatol. 2017;177:618-620.
    PubMed     Text format    


  560. HOLMES S, Harries M
    Re: Frontal Fibrosing Alopecia Severity Index (FFASI): a call for a more inclusive and globally relevant severity index for frontal fibrosing alopecia: reply from the authors.
    Br J Dermatol. 2017;177:884.
    PubMed     Text format    


  561. DLOVA NC, Dadzie OE
    Frontal Fibrosing Alopecia Severity Index (FFASI): a call for a more inclusive and globally relevant severity index for frontal fibrosing alopecia.
    Br J Dermatol. 2017;177:883-884.
    PubMed     Text format    


    August 2017
  562. MOSSNER R, Wilsmann-Theis D, Oji V, Gkogkolou P, et al
    The genetic basis for most patients with pustular skin disease remains elusive.
    Br J Dermatol. 2017 Aug 5. doi: 10.1111/bjd.15867.
    PubMed     Text format     Abstract available


  563. DAWE RS
    Maintenance therapy with psoralen-ultraviolet A for mycosis fungoides: in the absence of evidence sitting on the fence is appropriate.
    Br J Dermatol. 2017;177:337-338.
    PubMed     Text format    


  564. STEFANAKI C, Stratigos A
    Alopecia in Cronkhite-Canada syndrome.
    Br J Dermatol. 2017;177:348-349.
    PubMed     Text format    


  565. VIEYRA-GARCIA P, Wolf P
    Psoralen-ultraviolet A maintenance in mycosis fungoides: the underlying question.
    Br J Dermatol. 2017;177:336-337.
    PubMed     Text format    


  566. TAN J
    Updating the diagnosis, classification and assessment of rosacea by effacement of subtypes: reply from the author.
    Br J Dermatol. 2017;177:598-599.
    PubMed     Text format    


  567. WILKIN J
    Updating the diagnosis, classification and assessment of rosacea by effacement of subtypes.
    Br J Dermatol. 2017;177:597-598.
    PubMed     Text format    


  568. GELLER S, Sprecher E
    IgA pemphigus: lumping or splitting?
    Br J Dermatol. 2017;177:581-582.
    PubMed     Text format    


  569. BRUNASSO AMG, Massone C
    Alitretinoin therapy for palmoplantar pustulosis.
    Br J Dermatol. 2017;177:578-579.
    PubMed     Text format    


  570. TSAKOK T, Roberts E, Bridgett C, Staughton RCD, et al
    The effectiveness of habit reversal on treatment outcome and quality of life in patients with chronic eczema: a prospective observational study in the U.K.
    Br J Dermatol. 2017;177:554-556.
    PubMed     Text format    


    July 2017
  571. BAGOT M
    Folliculotropic mycosis fungoides is a heterogenous group.
    Br J Dermatol. 2017;177:17-18.
    PubMed     Text format    


  572. HAMMERS CM, Payne AS
    Clinical significance of immunoglobulin E in bullous pemphigoid.
    Br J Dermatol. 2017;177:13-14.
    PubMed     Text format    


  573. DAWE RS, McGuire VA
    Mild classical xeroderma pigmentosum.
    Br J Dermatol. 2017;177:21-22.
    PubMed     Text format    


  574. CALZAVARA-PINTON PG, Caravello S
    A practical approach to the initial dose and subsequent increments for ultraviolet A1 phototherapy.
    Br J Dermatol. 2017;177:19-20.
    PubMed     Text format    


  575. HATTA N
    New technology discloses the tumour margin of extramammary Paget disease?
    Br J Dermatol. 2017;177:18-19.
    PubMed     Text format    


  576. CHONG BF
    Pathogenesis of morphoea: knowledge gaps in subtypes and comparisons to systemic sclerosis.
    Br J Dermatol. 2017;177:9-10.
    PubMed     Text format    


  577. MAHER NG, Guitera P
    Imiquimod treatment for lentigo maligna: LIMIT-1 trial.
    Br J Dermatol. 2017;177:324-325.
    PubMed     Text format    


  578. STRAZZULLA LC, Avila L, Lo Sicco K, Shapiro J, et al
    Response to 'Frontal fibrosing alopecia in men: an association with facial moisturizers and sunscreens'.
    Br J Dermatol. 2017;177:323.
    PubMed     Text format    


  579. GIBBS DC, Ward SV, Orlow I, Cadby G, et al
    Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas.
    Br J Dermatol. 2017 Jul 1. doi: 10.1111/bjd.15784.
    PubMed     Text format     Abstract available


    June 2017
  580. ITO T
    Immune checkpoint inhibitor-associated alopecia areata.
    Br J Dermatol. 2017;176:1444-1445.
    PubMed     Text format    


  581. MURPHY M, Carmichael AJ
    Development of a multidimensional assessment tool for uraemic pruritus in dialysis patients - laying a foundation stone for itch research.
    Br J Dermatol. 2017;176:1432-1433.
    PubMed     Text format    


  582. BECATTI M
    Oxidative stress and high-mobility group box 1 (HMGB1) protein release in vitiligo.
    Br J Dermatol. 2017;176:1436-1437.
    PubMed     Text format    


  583. PATSATSI A, Murrell DF
    Multiple sclerosis is the neurological disorder most highly associated with bullous pemphigoid.
    Br J Dermatol. 2017;176:1428-1429.
    PubMed     Text format    


  584. LEGAT FJ, Wolf P
    Daylight photodynamic therapy: where and when is it possible?
    Br J Dermatol. 2017;176:1440-1441.
    PubMed     Text format    


  585. BOWER C
    Field treatment of actinic keratosis on the scalp.
    Br J Dermatol. 2017;176:1425-1426.
    PubMed     Text format    


  586. BASU TN
    Neutrophilic eccrine hidradenitis can be induced by BRAF inhibitors.
    Br J Dermatol. 2017;176:1443-1444.
    PubMed     Text format    


  587. TWO AM
    Minocycline as an alternative to doxycycline in the treatment of rosacea.
    Br J Dermatol. 2017;176:1426.
    PubMed     Text format    


  588. MCGRATH JA
    A new clinical diagnostic matrix for epidermolysis bullosa.
    Br J Dermatol. 2017;176:1442-1443.
    PubMed     Text format    


    May 2017
  589. SCARISBRICK JJ
    Prognostic factors in mycosis fungoides: international advances in the validation of prognostic indices.
    Br J Dermatol. 2017;176:1129-1130.
    PubMed     Text format    


  590. BRAATHEN LR
    Long methylaminolaevulinate application does not increase clinical efficacy of photodynamic therapy in actinic keratosis, but leads to collateral damage.
    Br J Dermatol. 2017;176:1121-1122.
    PubMed     Text format    


  591. TAMURA D, Khan SG, DiGiovanna JJ
    Molecular diagnosis of xeroderma pigmentosum variant in an isolated population: the interface between precision medicine and public health.
    Br J Dermatol. 2017;176:1125-1126.
    PubMed     Text format    


  592. APFELBACHER CJ
    Research questions for the treatment of alopecia areata have been prioritized.
    Br J Dermatol. 2017;176:1128-1129.
    PubMed     Text format    


  593. CUST AE
    Estimating the future health service burden of keratinocyte cancers in the U.K.
    Br J Dermatol. 2017;176:1107-1108.
    PubMed     Text format    


  594. HASHIMOTO T, Mizoguchi A
    Interleukin-10-producing B-cells in autoimmune bullous diseases.
    Br J Dermatol. 2017;176:1119-1120.
    PubMed     Text format    


  595. LEIJTEN EFA, Sigurdsson V, Wenink MH, Radstake TRDJ, et al
    Screening for psoriatic arthritis using the Psoriasis Epidemiology Screening Tool questionnaire: examining the optimal cut-off.
    Br J Dermatol. 2017;176:1357-1359.
    PubMed     Text format    


    April 2017
  596. THOMPSON AR, Bewley AP
    Meeting the psychological needs of dermatology patients.
    Br J Dermatol. 2017;176:858-859.
    PubMed     Text format    


  597. OFENLOCH RF
    Health-related quality of life in hidradenitis suppurativa.
    Br J Dermatol. 2017;176:861-862.
    PubMed     Text format    


  598. AGNER T, Nixon R
    Hand eczema is to be taken seriously ....
    Br J Dermatol. 2017;176:854-855.
    PubMed     Text format    


  599. BROWN SJ
    Evidence-based medicine for atopic eczema: identifying the knowns and unknowns.
    Br J Dermatol. 2017;176:842-844.
    PubMed     Text format    


  600. SCHREML S, Berneburg M
    The global burden of diabetic wounds.
    Br J Dermatol. 2017;176:845-846.
    PubMed     Text format    


  601. IBBOTSON SH
    Shedding light on drug photosensitivity reactions.
    Br J Dermatol. 2017;176:850-851.
    PubMed     Text format    


  602. CHU CY
    Measuring quality of life in infants, children and adolescents with eczema.
    Br J Dermatol. 2017;176:848-849.
    PubMed     Text format    


  603. HAMPTON P, Meggitt S
    Better definition of hidradenitis suppurativa subtypes is needed to progress disease-specific treatment outcomes.
    Br J Dermatol. 2017;176:862-863.
    PubMed     Text format    


  604. STOODLEY P
    Evidence for a biofilm-based treatment strategy in the management of chronic hidradenitis suppurativa.
    Br J Dermatol. 2017;176:855-856.
    PubMed     Text format    


  605. WHITE IR
    Quantitative risk assessment and the burden of fragrance contact allergy.
    Br J Dermatol. 2017;176:860-861.
    PubMed     Text format    


  606. KWON HS, Lee JH, Kim GM, Bae JM, et al
    Image Gallery: Subcutaneous fat necrosis of the newborn.
    Br J Dermatol. 2017;176:e32.
    PubMed     Text format    


    March 2017
  607. RAMZY AG, Lammintausta K, Matura M, B Christensson J, et al
    Isothiocyanates are important as haptens in contact allergy to chloroprene rubber.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15444.
    PubMed     Text format     Abstract available


  608. FINLAY AY
    Every dermatology consultation: think adherence.
    Br J Dermatol. 2017;176:558-559.
    PubMed     Text format    


  609. MAKRYGEORGOU A
    Secukinumab shows reassuring low immunogenicity.
    Br J Dermatol. 2017;176:573-574.
    PubMed     Text format    


    February 2017
  610. SU JC, Dailey R, Zallmann M, Leins E, et al
    Determining Effects of Superfine Sheep wool in INfantile Eczema (DESSINE): a randomized paediatric cross over study.
    Br J Dermatol. 2017 Feb 9. doi: 10.1111/bjd.15376.
    PubMed     Text format     Abstract available


    January 2017
  611. TASANI M, Glover M, Martinez AE, Shaw L, et al
    Atenolol Treatment for Infantile Haemangioma.
    Br J Dermatol. 2017 Jan 23. doi: 10.1111/bjd.15317.
    PubMed     Text format     Abstract available


  612. POLUBOTHU S, Kinsler VA
    The ethnicity profile of patients with birthmarks reveals interaction of germline and post-zygotic genetics.
    Br J Dermatol. 2017 Jan 13. doi: 10.1111/bjd.15260.
    PubMed     Text format     Abstract available


  613. DE BERKER D, McGregor JM, Mohd Mustapa MF, Exton LS, et al
    British Association of Dermatologists' guidelines for the care of patients with actinic keratosis 2017.
    Br J Dermatol. 2017;176:20-43.
    PubMed     Text format    


  614. FLYNN A, Molony P, Keeting C, Cullen J, et al
    Image Gallery: Systemic sarcoidosis presenting within the black pigment of a cosmetic tattoo.
    Br J Dermatol. 2017;176:e2.
    PubMed     Text format    


  615. TAN J, Steinhoff M, Berg M, Del Rosso J, et al
    Shortcomings in rosacea diagnosis and classification.
    Br J Dermatol. 2017;176:197-199.
    PubMed     Text format    


  616. TANG JQ, Ran X, Ran YP
    Cover Image: Dermoscopy in vivo for the life cycle of Phthirus pubis.
    Br J Dermatol. 2017;176:279.
    PubMed     Text format    


  617. INGRAM JR, Anstey A
    The evolution of clinical guidelines for dermatologists: GRADE, AGREE and occasionally consensus by experts.
    Br J Dermatol. 2017;176:3-4.
    PubMed     Text format    


    November 2016
  618. SPEIGL L, Janssen N, Weide B, Pawelec G, et al
    Prognostic impact of the putative cancer stem cell markers ABCG2, CD133, ALDH1A1 and CD44V7/8 in metastatic melanoma.
    Br J Dermatol. 2016 Nov 21. doi: 10.1111/bjd.15194.
    PubMed     Text format     Abstract available


  619. KOPPES SA, Ljubojevic Hadzavdic S, Jakasa I, Franceschi N, et al
    Stratum corneum profiles of inflammatory mediators in patch test reactions to common contact allergens and sodium lauryl sulfate.
    Br J Dermatol. 2016 Nov 4. doi: 10.1111/bjd.15163.
    PubMed     Text format     Abstract available


  620. BERENTS TL, Lodrup Carlsen KC, Mowinckel P, Skjerven HO, et al
    Transepidermal water loss in infancy associated with atopic eczema at 2 years: a population-based cohort study.
    Br J Dermatol. 2016 Nov 3. doi: 10.1111/bjd.15157.
    PubMed     Text format     Abstract available


    August 2016
  621. MOSE KF, Andersen F, Skov L, Ropke MA, et al
    Repeated monthly epicutaneous challenges with diphenylcyclopropenone result in a clinically reproducible level of contact allergy in de novo sensitized individuals.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14949.
    PubMed     Text format     Abstract available


    July 2016
  622. TULL TJ, Noy M, Bunker CB, Francis ND, et al
    Sebopsoriasis in HIV positive patients: A case series of twenty patients.
    Br J Dermatol. 2016 Jul 22. doi: 10.1111/bjd.14874.
    PubMed     Text format     Abstract available


    April 2016
  623. OREGAARD JS, Jarjis RD, Venzo A, Jemec B, et al
    Cover Image: Unique presentation of a subungual malignant melanoma in situ.
    Br J Dermatol. 2016;174:935.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: